Michael Freedman, M.Phil. - Publications

Affiliations: 
Genentech, Inc., San Francisco, CA, United States 

500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Weinstock-Guttman B, Bermel R, Cutter G, Freedman MS, Leist TP, Ma X, Kile D, Musch B, Reder AT, Wolinsky JS. Ocrelizumab treatment for relapsing-remitting multiple sclerosis after a suboptimal response to previous disease-modifying therapy: A nonrandomized controlled trial. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585211035740. PMID 34382875 DOI: 10.1177/13524585211035740  1
2021 Bose G, Rush C, Atkins HL, Freedman MS. A real-world single-centre analysis of alemtuzumab and cladribine for multiple sclerosis. Multiple Sclerosis and Related Disorders. 52: 102945. PMID 33901969 DOI: 10.1016/j.msard.2021.102945  1
2021 Thebault S, Booth RA, Rush CA, MacLean H, Freedman MS. Serum Neurofilament Light Chain Measurement in MS: Hurdles to Clinical Translation. Frontiers in Neuroscience. 15: 654942. PMID 33841093 DOI: 10.3389/fnins.2021.654942  1
2021 Kappos L, Fox RJ, Burcklen M, Freedman MS, Havrdová EK, Hennessy B, Hohlfeld R, Lublin F, Montalban X, Pozzilli C, Scherz T, D'Ambrosio D, Linscheid P, Vaclavkova A, Pirozek-Lawniczek M, et al. Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study: A Randomized Clinical Trial. Jama Neurology. PMID 33779698 DOI: 10.1001/jamaneurol.2021.0405  1
2021 Beacham MC, McMillen WP, Kirkman SS, Maxey DK, Freedman M, Tillmann HL. "On demand" sedation for colonoscopy with or without auricular acupuncture is non-inferior and may improve quality metrics compared to "upfront" sedation. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association For the Study of the Liver. PMID 33737006 DOI: 10.1016/j.dld.2021.02.023  1
2021 Freedman MS, Coyle PK, Comi G, L Scarberry S, Damian D, Hyvert Y, Dangond F, Galazka A, Jack D, Lebson LA, Leist TP. Early MRI outcomes in participants with a first clinical demyelinating event at risk of multiple sclerosis in the ORACLE-MS study. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 7: 2055217321990852. PMID 33717501 DOI: 10.1177/2055217321990852  1
2021 Sormani MP, Freedman MS, Aldridge J, Marhardt K, Kappos L, De Stefano N. MAGNIMS score predicts long-term clinical disease activity-free status and confirmed disability progression in patients treated with subcutaneous interferon beta-1a. Multiple Sclerosis and Related Disorders. 49: 102790. PMID 33571946 DOI: 10.1016/j.msard.2021.102790  1
2021 Das J, Snowden JA, Burman J, Freedman MS, Atkins H, Bowman M, Burt RK, Saccardi R, Innocenti C, Mistry S, Laud PJ, Jessop H, Sharrack B. Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with 'aggressive' multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520985238. PMID 33565902 DOI: 10.1177/1352458520985238  1
2020 Horáková D, Boster A, Bertolotto A, Freedman MS, Firmino I, Cavalier SJ, Jacobs AK, Thangavelu K, Daizadeh N, Poole EM, Baker DP, Margolin DH, Ziemssen T. Proportion of alemtuzumab-treated patients converting from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis over 6 years. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 6: 2055217320972137. PMID 33414927 DOI: 10.1177/2055217320972137  1
2020 Cree BAC, Cutter G, Wolinsky JS, Freedman MS, Comi G, Giovannoni G, Hartung HP, Arnold D, Kuhle J, Block V, Munschauer FE, Sedel F, Lublin FD. Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet. Neurology. 19: 988-997. PMID 33222767 DOI: 10.1016/S1474-4422(20)30347-1  1
2020 Hartung HP, Berger T, Bermel RA, Brochet B, Carroll WM, Holmøy T, Karabudak R, Killestein J, Nos C, Patti F, Ross AP, Vanopdenbosch L, Vollmer T, Buffels R, Garas M, ... ... Freedman MS, et al. Shorter infusion time of ocrelizumab: Results from the randomized, double-blind ENSEMBLE PLUS substudy in patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis and Related Disorders. 46: 102492. PMID 33039944 DOI: 10.1016/j.msard.2020.102492  1
2020 Comi G, Freedman MS, Meca-Lallana JE, Vermersch P, Kim BJ, Parajeles A, Edwards KR, Gold R, Korideck H, Chavin J, Poole EM, Coyle PK. Prior treatment status: impact on the efficacy and safety of teriflunomide in multiple sclerosis. Bmc Neurology. 20: 364. PMID 33023488 DOI: 10.1186/s12883-020-01937-4  1
2020 Miller AE, Olsson TP, Wolinsky JS, Comi G, Kappos L, Hu X, Xu X, Lublin AL, Truffinet P, Chavin J, Delhay JL, Benamor M, Purvis A, Freedman MS. Long-term safety and efficacy of teriflunomide in patients with relapsing multiple sclerosis: Results from the TOWER extension study. Multiple Sclerosis and Related Disorders. 46: 102438. PMID 32911306 DOI: 10.1016/j.msard.2020.102438  1
2020 Freedman MS, Devonshire V, Duquette P, Giacomini PS, Giuliani F, Levin MC, Montalban X, Morrow SA, Oh J, Rotstein D, Yeh EA. Treatment Optimization in Multiple Sclerosis: Canadian MS Working Group Recommendations. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 47: 437-455. PMID 32654681 DOI: 10.1017/cjn.2020.66  1
2020 Tillmann HL, Nelson WR, Freedman M. Opioid weaning made possible by pain control with Battlefield Acupuncture. Acupuncture in Medicine : Journal of the British Medical Acupuncture Society. 964528420929342. PMID 32623907 DOI: 10.1177/0964528420929342  1
2020 Thebault S, Abdoli M, Fereshtehnejad SM, Tessier D, Tabard-Cossa V, Freedman MS. Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis. Scientific Reports. 10: 10381. PMID 32587320 DOI: 10.1038/s41598-020-67504-6  1
2020 Bose G, Thebault S, Rush CA, Atkins HL, Freedman MS. Autologous hematopoietic stem cell transplantation for multiple sclerosis: A current perspective. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520917936. PMID 32364422 DOI: 10.1177/1352458520917936  1
2020 Thebault S, Lee H, Bose G, Tessier D, Abdoli M, Bowman M, Berard J, Walker L, Rush CA, MacLean H, Booth RA, Narayanan S, Arnold DL, Tabard-Cossa V, Atkins HL, ... Freedman MS, et al. Neurotoxicity after hematopoietic stem cell transplant in multiple sclerosis. Annals of Clinical and Translational Neurology. PMID 32304358 DOI: 10.1002/acn3.51045  1
2020 Cortese M, Munger KL, Martínez-Lapiscina EH, Barro C, Edan G, Freedman MS, Hartung HP, Montalbán X, Foley FW, Penner IK, Hemmer B, Fox EJ, Schippling S, Wicklein EM, Kappos L, et al. Vitamin D, smoking, EBV, and long-term cognitive performance in MS: 11-year follow-up of BENEFIT. Neurology. PMID 32300060 DOI: 10.1212/Wnl.0000000000009371  1
2020 Ziemssen T, Piani-Meier D, Bennett B, Johnson C, Tinsley K, Trigg A, Hach T, Dahlke F, Tomic D, Tolley C, Freedman MS. A Physician-Completed Digital Tool for Evaluating Disease Progression (Multiple Sclerosis Progression Discussion Tool): Validation Study. Journal of Medical Internet Research. 22: e16932. PMID 32049062 DOI: 10.2196/16932  1
2020 Naismith RT, Wundes A, Ziemssen T, Jasinska E, Freedman MS, Lembo AJ, Selmaj K, Bidollari I, Chen H, Hanna J, Leigh-Pemberton R, Lopez-Bresnahan M, Lyons J, Miller C, Rezendes D, et al. Diroximel Fumarate Demonstrates an Improved Gastrointestinal Tolerability Profile Compared with Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III EVOLVE-MS-2 Study. Cns Drugs. PMID 31953790 DOI: 10.1007/s40263-020-00700-0  1
2019 Walker LAS, Gardner C, Freedman MS, MacLean H, Rush C, Bowman M. Research-to-Practice Gaps in Multiple Sclerosis Care for Patients with Subjective Cognitive, Mental Health, and Psychosocial Concerns in a Canadian Center. International Journal of Ms Care. 21: 243-248. PMID 31889928 DOI: 10.7224/1537-2073.2017-090  1
2019 Freedman MS, Comi G, Coyle PK, Aldridge J, Chen L, Marhardt K, Kappos L. No evidence of disease activity status in patients treated with early vs. delayed subcutaneous interferon β-1a. Multiple Sclerosis and Related Disorders. 39: 101891. PMID 31864098 DOI: 10.1016/j.msard.2019.101891  1
2019 Law MT, Traboulsee AL, Li DK, Carruthers RL, Freedman MS, Kolind SH, Tam R. Machine learning in secondary progressive multiple sclerosis: an improved predictive model for short-term disability progression. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 5: 2055217319885983. PMID 31723436 DOI: 10.1177/2055217319885983  1
2019 Naismith RT, Wolinsky JS, Wundes A, LaGanke C, Arnold DL, Obradovic D, Freedman MS, Gudesblatt M, Ziemssen T, Kandinov B, Bidollari I, Lopez-Bresnahan M, Nangia N, Rezendes D, Yang L, et al. Diroximel fumarate (DRF) in patients with relapsing-remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519881761. PMID 31680631 DOI: 10.1177/1352458519881761  1
2019 Van Wijmeersch B, Singer BA, Boster A, Broadley S, Fernández Ó, Freedman MS, Izquierdo G, Lycke J, Pozzilli C, Sharrack B, Steingo B, Wiendl H, Wray S, Ziemssen T, Chung L, et al. Efficacy of alemtuzumab over 6 years in relapsing-remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519881759. PMID 31675266 DOI: 10.1177/1352458519881759  1
2019 Freedman MS, Brod S, Singer BA, Cohen BA, Hayward B, Dangond F, Coyle PK. Clinical and MRI efficacy of sc IFN β-1a tiw in patients with relapsing MS appearing to transition to secondary progressive MS: post hoc analyses of PRISMS and SPECTRIMS. Journal of Neurology. PMID 31559532 DOI: 10.1007/s00415-019-09532-5  1
2019 Thebault S, R Tessier D, Lee H, Bowman M, Bar-Or A, Arnold DL, L Atkins H, Tabard-Cossa V, Freedman MS. High serum neurofilament light chain normalizes after hematopoietic stem cell transplantation for MS. Neurology(R) Neuroimmunology & Neuroinflammation. 6: e598. PMID 31516913 DOI: 10.1212/NXI.0000000000000598  1
2019 Bose G, Thebault SDX, Atkins HL, Freedman MS. Does resetting the immune system fix multiple sclerosis? The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 1-35. PMID 31511117 DOI: 10.1017/cjn.2019.294  1
2019 Berard JA, Fang Z, Walker LAS, Lindsay-Brown A, Osman L, Cameron I, Cruce R, Cron GO, Freedman MS, Smith AM. Imaging cognitive fatigability in multiple sclerosis: objective quantification of cerebral blood flow during a task of sustained attention using ASL perfusion fMRI. Brain Imaging and Behavior. PMID 31468375 DOI: 10.1007/S11682-019-00192-7  1
2019 Miller AE, Vermersch P, Kappos L, Comi G, Freedman MS, Oh J, de Seze J, Truffinet P, Benamor M, Purvis A, Wolinsky JS. Long-term outcomes with teriflunomide in patients with clinically isolated syndrome: Results of the TOPIC extension study. Multiple Sclerosis and Related Disorders. 33: 131-138. PMID 31195337 DOI: 10.1016/j.msard.2019.05.014  1
2019 Freedman MS, Beer L, Mattson CL, Sullivan PS, Skarbinski J. Behavioral and Clinical Characteristics of Self-Identified Bisexual Men Living with HIV Receiving Medical Care in the United States-Medical Monitoring Project, 2009-2013. Journal of Homosexuality. 1-19. PMID 31173564 DOI: 10.1080/00918369.2019.1621553  1
2019 Comi G, Miller AE, Benamor M, Truffinet P, Poole EM, Freedman MS. Characterizing lymphocyte counts and infection rates with long-term teriflunomide treatment: Pooled analysis of clinical trials. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519851981. PMID 31172849 DOI: 10.1177/1352458519851981  1
2019 Uccelli A, Laroni A, Brundin L, Clanet M, Fernandez O, Nabavi SM, Muraro PA, Oliveri RS, Radue EW, Sellner J, Soelberg Sorensen P, Sormani MP, Wuerfel JT, Battaglia MA, Freedman MS, et al. MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis. Trials. 20: 263. PMID 31072380 DOI: 10.1186/s13063-019-3346-z  1
2019 Ackermans N, Taylor C, Tam R, Carruthers R, Kolind S, Kang H, Freedman MS, Li DK, Traboulsee AL. Effect of different doses of gadolinium contrast agent on clinical outcomes in MS. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 5: 2055217318823796. PMID 30800415 DOI: 10.1177/2055217318823796  1
2019 Cohen JA, Baldassari LE, Atkins HL, Bowen JD, Bredeson C, Carpenter PA, Corboy JR, Freedman MS, Griffith LM, Lowsky R, Majhail NS, Muraro PA, Nash RA, Pasquini MC, Sarantopoulos S, et al. AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION FOR TREATMENT-REFRACTORY RELAPSING MULTIPLE SCLEROSIS: POSITION STATEMENT FROM THE AMERICAN SOCIETY FOR BLOOD AND MARROW TRANSPLANTATION. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 30794930 DOI: 10.1016/j.bbmt.2019.02.014  1
2019 Freedman MS, Duquette P, Grand'Maison F, Lee L, Vorobeychik G, Lara N, Khurana V, Nakhaipour HR, Schecter R, Haddad P. The clinical and cost impact of switching to fingolimod versus other first line injectable disease modifying therapies in patients with relapsing multiple sclerosis. Current Medical Research and Opinion. 1. PMID 30614288 DOI: 10.1080/03007995.2019.1565818  1
2018 Abdelfatah MM, Beacham MC, Freedman M, Tillmann HL. Can Battlefield Acupuncture Improve Colonoscopy Experience? Medical Acupuncture. 30: 279-281. PMID 30377464 DOI: 10.1089/acu.2018.1289  1
2018 Freedman M, Bierwirth PA. Pragmatic Use of Acupuncture in a Neurology Practice: Experience in an Outpatient Veterans Administration Neurology Clinic. Medical Acupuncture. 30: 242-244. PMID 30377458 DOI: 10.1089/acu.2018.1290  0.01
2018 Cadavid D, Balcer L, Galetta S, Aktas O, Ziemssen T, Vanopdenbosch LJ, Leocani L, Freedman MS, Plant GT, Preiningerova JL, Ziemssen F, Massacesi L, Chai Y, Xu L. Predictors of response to opicinumab in acute optic neuritis. Annals of Clinical and Translational Neurology. 5: 1154-1162. PMID 30349850 DOI: 10.1002/Acn3.620  1
2018 Miller AE, Xu X, Macdonell R, Vucic S, Truffinet P, Benamor M, Thangavelu K, Freedman MS. Efficacy and safety of teriflunomide in Asian patients with relapsing forms of multiple sclerosis: A subgroup analysis of the phase 3 TOWER study. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. PMID 30348586 DOI: 10.1016/j.jocn.2018.09.012  1
2018 Bose G, Atkins HL, Bowman M, Freedman MS. Autologous hematopoietic stem cell transplantation improves fatigue in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458518802544. PMID 30251913 DOI: 10.1177/1352458518802544  1
2018 Bendfeldt K, Taschler B, Gaetano L, Madoerin P, Kuster P, Mueller-Lenke N, Amann M, Vrenken H, Wottschel V, Barkhof F, Borgwardt S, Klöppel S, Wicklein EM, Kappos L, Edan G, Freedman MS, et al. MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry. Brain Imaging and Behavior. PMID 30155789 DOI: 10.1007/S11682-018-9942-9  1
2018 Kang H, Hii M, Le M, Tam R, Riddehough A, Traboulsee A, Kolind S, Freedman MS, Li DKB. Gadolinium Deposition in Deep Brain Structures: Relationship with Dose and Ionization of Linear Gadolinium-Based Contrast Agents. Ajnr. American Journal of Neuroradiology. PMID 30139752 DOI: 10.3174/Ajnr.A5751  1
2018 Freedman MS, Selchen D, Prat A, Giacomini PS. Managing Multiple Sclerosis: Treatment Initiation, Modification, and Sequencing. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 1-15. PMID 29893652 DOI: 10.1017/Cjn.2018.17  1
2018 Darlington PJ, Stopnicki B, Touil T, Doucet JS, Fawaz L, Roberts ME, Boivin MN, Arbour N, Freedman MS, Atkins HL, Bar-Or A. Natural Killer Cells Regulate Th17 Cells After Autologous Hematopoietic Stem Cell Transplantation for Relapsing Remitting Multiple Sclerosis. Frontiers in Immunology. 9: 834. PMID 29867923 DOI: 10.3389/fimmu.2018.00834  1
2018 Burton JM, Freedman MS. The Shifting Landscape of Disease-Modifying Therapies for Relapsing Multiple Sclerosis. Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society. 38: 210-216. PMID 29750735 DOI: 10.1097/WNO.0000000000000659  1
2018 Rush CA, Atkins HL, Freedman MS. Autologous Hematopoietic Stem Cell Transplantation in the Treatment of Multiple Sclerosis. Cold Spring Harbor Perspectives in Medicine. PMID 29610145 DOI: 10.1101/cshperspect.a029082  1
2018 Miller DH, Lublin FD, Sormani MP, Kappos L, Yaldizli Ö, Freedman MS, Cree BAC, Weiner HL, Lubetzki C, Hartung HP, Montalban X, Uitdehaag BMJ, MacManus DG, Yousry TA, Gandini Wheeler-Kingshott CAM, et al. Brain atrophy and disability worsening in primary progressive multiple sclerosis: insights from the INFORMS study. Annals of Clinical and Translational Neurology. 5: 346-356. PMID 29560379 DOI: 10.1002/Acn3.534  1
2018 Kapoor R, Ho PR, Campbell N, Chang I, Deykin A, Forrestal F, Lucas N, Yu B, Arnold DL, Freedman MS, Goldman MD, Hartung HP, Havrdová EK, Jeffery D, Miller A, et al. Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension. The Lancet. Neurology. PMID 29545067 DOI: 10.1016/S1474-4422(18)30069-3  1
2018 Buck D, Andlauer TF, Igl W, Wicklein EM, Mühlau M, Weber F, Köchert K, Pohl C, Arnason B, Comi G, Cook S, Filippi M, Hartung HP, Jeffery D, Kappos L, ... Freedman MS, et al. Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458518763089. PMID 29521573 DOI: 10.1177/1352458518763089  1
2018 Patel AI, Moghadam SD, Freedman M, Hazari A, Fang ML, Allen I. The association of flavored milk consumption with milk and energy intake, and obesity: A systematic review. Preventive Medicine. PMID 29501475 DOI: 10.1016/j.ypmed.2018.02.031  0.01
2018 Freedman M, Jackson BR, McCotter O, Benedict K. Coccidioidomycosis Outbreaks, United States and Worldwide, 1940-2015. Emerging Infectious Diseases. 24: 417-423. PMID 29460741 DOI: 10.3201/eid2403.170623  0.01
2018 Freedman M, Comi G, Coyle PK, Aldridge J, Marhardt K, Kappos L. Impact of Gadolinium-enhancing (GD+) Lesions on No Evidence of Disease Activity (NEDA) Status in Subcutaneous Interferon Beta-1a (SC IFNβ-1a)-treated Patients Multiple Sclerosis and Related Disorders. 26: 239-240. DOI: 10.1016/J.Msard.2018.10.035  1
2017 Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. The Lancet. Neurology. PMID 29275977 DOI: 10.1016/S1474-4422(17)30470-2  1
2017 Freedman MS, Leist TP, Comi G, Cree BA, Coyle PK, Hartung HP, Vermersch P, Damian D, Dangond F. The efficacy of cladribine tablets in CIS patients retrospectively assigned the diagnosis of MS using modern criteria: Results from the ORACLE-MS study. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 3: 2055217317732802. PMID 29051829 DOI: 10.1177/2055217317732802  1
2017 Vermersch P, Radue EW, Putzki N, Ritter S, Merschhemke M, Freedman MS. A comparison of multiple sclerosis disease activity after discontinuation of fingolimod and placebo. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 3: 2055217317730096. PMID 28989795 DOI: 10.1177/2055217317730096  1
2017 Atkins HL, Freedman MS. Five Questions Answered: A Review of Autologous Hematopoietic Stem Cell Transplantation for the Treatment of Multiple Sclerosis. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 28822119 DOI: 10.1007/s13311-017-0564-5  1
2017 Coyle PK, Reder AT, Freedman MS, Fang J, Dangond F. Early MRI results and odds of attaining 'no evidence of disease activity' status in MS patients treated with interferon β-1a in the EVIDENCE study. Journal of the Neurological Sciences. 379: 151-156. PMID 28716230 DOI: 10.1016/j.jns.2017.05.052  1
2017 Lee H, Nakamura K, Narayanan S, Brown R, Chen J, Atkins HL, Freedman MS, Arnold DL. Impact of immunoablation and autologous hematopoietic stem cell transplantation on gray and white matter atrophy in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517715811. PMID 28617152 DOI: 10.1177/1352458517715811  1
2017 Metz LM, Li DKB, Traboulsee AL, Duquette P, Eliasziw M, Cerchiaro G, Greenfield J, Riddehough A, Yeung M, Kremenchutzky M, Vorobeychik G, Freedman MS, Bhan V, Blevins G, Marriott JJ, et al. Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis. The New England Journal of Medicine. 376: 2122-2133. PMID 28564557 DOI: 10.1056/Nejmoa1608889  1
2017 Fitzgerald KC, Munger KL, Hartung HP, Freedman MS, Montalbán X, Edan G, Wicklein EM, Radue EW, Kappos L, Pohl C, Ascherio A. Sodium intake and multiple sclerosis activity and progression in BENEFIT. Annals of Neurology. PMID 28556498 DOI: 10.1002/Ana.24965  1
2017 Sartori A, Abdoli M, Freedman MS. Can we predict benign multiple sclerosis? Results of a 20-year long-term follow-up study. Journal of Neurology. PMID 28417192 DOI: 10.1007/s00415-017-8487-y  1
2017 Freedman MS, Wolinsky JS, Comi G, Kappos L, Olsson TP, Miller AE, Thangavelu K, Benamor M, Truffinet P, O'Connor PW. The efficacy of teriflunomide in patients who received prior disease-modifying treatments: Subgroup analyses of the teriflunomide phase 3 TEMSO and TOWER studies. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517695468. PMID 28304217 DOI: 10.1177/1352458517695468  1
2017 Atkins H, Freedman MS. Immunoablation and aHSCT for aggressive multiple sclerosis - Authors' reply. Lancet (London, England). 389: 908. PMID 28271842 DOI: 10.1016/S0140-6736(17)30592-5  1
2017 Muraro PA, Pasquini M, Atkins HL, Bowen JD, Farge D, Fassas A, Freedman MS, Georges GE, Gualandi F, Hamerschlak N, Havrdova E, Kimiskidis VK, Kozak T, Mancardi GL, Massacesi L, et al. Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis. Jama Neurology. PMID 28241268 DOI: 10.1001/Jamaneurol.2016.5867  1
2017 Baugher AR, Beer L, Fagan JL, Mattson CL, Freedman M, Skarbinski J, Shouse RL. Prevalence of Internalized HIV-Related Stigma Among HIV-Infected Adults in Care, United States, 2011-2013. Aids and Behavior. PMID 28213821 DOI: 10.1007/s10461-017-1712-y  1
2017 Macdonell R, Freedman M, Xu X, Vucic S, Truffinet P, Benamor M, Thangavelu K, Miller A. Efficacy and safety of teriflunomide in Chinese patients with relapsing forms of MS: A subgroup analysis of the phase 3 tower study Journal of the Neurological Sciences. 381: 135. DOI: 10.1016/J.Jns.2017.08.403  1
2016 Comi G, De Stefano N, Freedman MS, Barkhof F, Uitdehaag BM, de Vos M, Marhardt K, Chen L, Issard D, Kappos L. Subcutaneous interferon β-1a in the treatment of clinically isolated syndromes: 3-year and 5-year results of the phase III dosing frequency-blind multicentre REFLEXION study. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 28039317 DOI: 10.1136/Jnnp-2016-314843  1
2016 Abdoli M, Chakraborty S, MacLean HJ, Freedman MS. The evaluation of MRI diffusion values of active demyelinating lesions in multiple sclerosis. Multiple Sclerosis and Related Disorders. 10: 97-102. PMID 27919508 DOI: 10.1016/j.msard.2016.09.006  1
2016 Freedman MS, Montalban X, Miller AE, Dive-Pouletty C, Hass S, Thangavelu K, Leist TP. Comparing outcomes from clinical studies of oral disease-modifying therapies (dimethyl fumarate, fingolimod, and teriflunomide) in relapsing MS: Assessing absolute differences using a number needed to treat analysis. Multiple Sclerosis and Related Disorders. 10: 204-212. PMID 27919491 DOI: 10.1016/j.msard.2016.10.010  1
2016 Lin X, Mattson CL, Freedman M, Skarbinski J. Erectile Dysfunction Medication Prescription and Condomless Intercourse in HIV-Infected Men Who have Sex with Men in the United States. Aids and Behavior. PMID 27637499 DOI: 10.1007/s10461-016-1552-1  1
2016 Kappos L, Edan G, Freedman MS, Montalbán X, Hartung HP, Hemmer B, Fox EJ, Barkhof F, Schippling S, Schulze A, Pleimes D, Pohl C, Sandbrink R, Suarez G, Wicklein EM, et al. The 11-year long-term follow-up study from the randomized BENEFIT CIS trial. Neurology. PMID 27511182 DOI: 10.1212/Wnl.0000000000003078  1
2016 Khoury SJ, Rochon J, Ding L, Byron M, Ryker K, Tosta P, Gao W, Freedman MS, Arnold DL, Sayre PH, Smilek DE. ACCLAIM: A randomized trial of abatacept (CTLA4-Ig) for relapsing-remitting multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 27481207 DOI: 10.1177/1352458516662727  1
2016 Freedman M, Atkins HL. Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - YES. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 27444560 DOI: 10.1177/1352458516654311  1
2016 Kappos L, Li DK, Stüve O, Hartung HP, Freedman MS, Hemmer B, Rieckmann P, Montalban X, Ziemssen T, Hunter B, Arnould S, Wallström E, Selmaj K. Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis: Dose-Blinded, Randomized Extension of the Phase 2 BOLD Study. Jama Neurology. PMID 27380540 DOI: 10.1001/Jamaneurol.2016.1451  1
2016 Menon S, Zhu F, Shirani A, Oger J, Freedman MS, Tremlett H. Disability progression in aggressive multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 27325603 DOI: 10.1177/1352458516653273  1
2016 Atkins HL, Bowman M, Allan D, Anstee G, Arnold DL, Bar-Or A, Bence-Bruckler I, Birch P, Bredeson C, Chen J, Fergusson D, Halpenny M, Hamelin L, Huebsch L, Hutton B, ... Freedman MS, et al. Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial. Lancet (London, England). PMID 27291994 DOI: 10.1016/S0140-6736(16)30169-6  1
2016 Freedman MS, Rush CA. Severe, Highly Active, or Aggressive Multiple Sclerosis. Continuum (Minneapolis, Minn.). 22: 761-784. PMID 27261681 DOI: 10.1212/CON.0000000000000331  1
2016 Lee H, Narayanan S, Brown RA, Chen JT, Atkins HL, Freedman MS, Arnold DL. Brain atrophy after bone marrow transplantation for treatment of multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 27246142 DOI: 10.1177/1352458516650992  1
2016 Cadavid D, Cohen JA, Freedman MS, Goldman MD, Hartung HP, Havrdova E, Jeffery D, Kapoor R, Miller A, Sellebjerg F, Kinch D, Lee S, Shang S, Mikol D. The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 27003945 DOI: 10.1177/1352458516638941  1
2016 Walker LA, Osman L, Berard JA, Rees LM, Freedman MS, MacLean H, Cousineau D. Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Canadian contribution to the international validation project. Journal of the Neurological Sciences. 362: 147-52. PMID 26944137 DOI: 10.1016/j.jns.2016.01.040  1
2016 Lapierre Y, O'Connor P, Devonshire V, Freedman MS, Kremenchutzky M, Yeung M, Schecter R. Canadian Experience with Fingolimod: Adherence to Treatment and Monitoring. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 43: 278-83. PMID 26890887 DOI: 10.1017/cjn.2015.325  1
2016 O'Connor P, Comi G, Freedman MS, Miller AE, Kappos L, Bouchard JP, Lebrun-Frenay C, Mares J, Benamor M, Thangavelu K, Liang J, Truffinet P, Lawson VJ, Wolinsky JS, et al. Long-term safety and efficacy of teriflunomide: Nine-year follow-up of the randomized TEMSO study. Neurology. PMID 26865517 DOI: 10.1212/WNL.0000000000002441  1
2016 Comi G, Freedman MS, Kappos L, Olsson TP, Miller AE, Wolinsky JS, O'Connor PW, Benamor M, Dukovic D, Truffinet P, Leist TP. Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions. Multiple Sclerosis and Related Disorders. 5: 97-104. PMID 26856952 DOI: 10.1016/j.msard.2015.11.006  1
2016 Lublin F, Miller DH, Freedman MS, Cree BA, Wolinsky JS, Weiner H, Lubetzki C, Hartung HP, Montalban X, Uitdehaag BM, Merschhemke M, Li B, Putzki N, Liu FC, Häring DA, et al. Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet (London, England). PMID 26827074 DOI: 10.1016/S0140-6736(15)01314-8  1
2016 Brown EE, Graff-Guerrero A, Houle S, Mizrahi R, Wilson AA, Pollock BG, Mulsant BH, Felsky D, Voineskos AN, Tang-Wai DF, Verhoeff NP, Freedman M, Ismail Z, Chow TW. Amyloid deposition in semantic dementia: a positron emission tomography study. International Journal of Geriatric Psychiatry. PMID 26807731 DOI: 10.1002/gps.4423  1
2016 Cui SX, Freedman MH, Wang Z. Complexity classes as mathematical axioms II Quantum Topology. 7: 185-201. DOI: 10.4171/Qt/75  1
2016 Anderson BJ, Jasinski JP, Freedman MB, Millikan SP, O’Rourke KA, Smolenski VA. Synthesis, crystal structural investigations, and DFT calculations of novel thiosemicarbazones Crystals. 6. DOI: 10.3390/cryst6020017  1
2016 D’Ambrosio D, Freedman MS, Prinz J. Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases Therapeutic Advances in Chronic Disease. 7: 18-33. DOI: 10.1177/2040622315617354  1
2016 Freedman MR, King JK. Examining a New “Pay-as-You-Go” Community-Supported Agriculture (CSA) Model: A Case Study Journal of Hunger and Environmental Nutrition. 1-24. DOI: 10.1080/19320248.2015.1045671  1
2016 Mäurer M, Comi G, Freedman MS, Kappos L, Olsson TP, Wolinsky JS, Miller AE, Dive-Pouletty C, Bozzi S, O'Connor PW. Multiple sclerosis relapses are associated with increased fatigue and reduced health-related quality of life - A post hoc analysis of the TEMSO and TOWER studies Multiple Sclerosis and Related Disorders. 7: 33-40. DOI: 10.1016/j.msard.2016.02.012  1
2016 Freedman MJ, Hazay C, Nissim K, Pinkas B. Efficient Set Intersection with Simulation-Based Security Journal of Cryptology. 29: 115-155. DOI: 10.1007/s00145-014-9190-0  1
2015 Freedman MS, Wolinsky JS, Truffinet P, Comi G, Kappos L, Miller AE, Olsson TP, Benamor M, Chambers S, O'Connor PW. A randomized trial of teriflunomide added to glatiramer acetate in relapsing multiple sclerosis. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 1: 2055217315618687. PMID 28607708 DOI: 10.1177/2055217315618687  1
2015 Petrovics G, Li H, Stümpel T, Tan SH, Young D, Katta S, Li Q, Ying K, Klocke B, Ravindranath L, Kohaar I, Chen Y, Ribli D, Grote K, Zou H, ... ... Freedman M, et al. A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men. Ebiomedicine. 2: 1957-64. PMID 26844274 DOI: 10.1016/J.Ebiom.2015.10.028  1
2015 Selim AM, Ray C, Cusimano MD, Karp E, Freedman M. Reversible long-standing severe disability in idiopathic normal pressure hydrocephalus. Neurology. Clinical Practice. 5: 505-508. PMID 26716064 DOI: 10.1212/CPJ.0000000000000149  1
2015 Freedman MR, Fulgoni VL. Canned Vegetable and Fruit Consumption Is Associated with Changes in Nutrient Intake and Higher Diet Quality in Children and Adults: National Health and Nutrition Examination Survey 2001-2010. Journal of the Academy of Nutrition and Dietetics. PMID 26617186 DOI: 10.1016/j.jand.2015.10.013  1
2015 Anderson BJ, Freedman MB, Smolenski VA, Jasinski JP. The crystal structure of 1-(2-hydroxy-5-meth-oxy-phen-yl)ethanone 4,4-di-methyl-thio-semicarbazone. Acta Crystallographica. Section E, Crystallographic Communications. 71: o811-o812. PMID 26594539 DOI: 10.1107/S2056989015018228  1
2015 Anderson BJ, Freedman MB, Millikan SP, Smolenski VA, Jasinski JP. Crystal structure of 2-[2-(hy-droxy-imino)-1-phenyl-propyl-idene]-N-phen-ylhydrazinecarbo-thio-amide. Acta Crystallographica. Section E, Crystallographic Communications. 71: o796-o797. PMID 26594484 DOI: 10.1107/S2056989015017739  1
2015 Abdoli M, Freedman MS. Neuro-oncology dilemma: Tumour or tumefactive demyelinating lesion. Multiple Sclerosis and Related Disorders. 4: 555-66. PMID 26590662 DOI: 10.1016/j.msard.2015.07.013  1
2015 Kappos L, De Stefano N, Freedman MS, Cree BA, Radue EW, Sprenger T, Sormani MP, Smith T, Häring DA, Piani Meier D, Tomic D. Inclusion of brain volume loss in a revised measure of 'no evidence of disease activity' (NEDA-4) in relapsing-remitting multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26585439 DOI: 10.1177/1352458515616701  1
2015 Freedman MS. Are we in need of NEDA? Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26552731 DOI: 10.1177/1352458515617249  1
2015 Brega AG, Freedman MA, LeBlanc WG, Barnard J, Mabachi NM, Cifuentes M, Albright K, Weiss BD, Brach C, West DR. Using the Health Literacy Universal Precautions Toolkit to Improve the Quality of Patient Materials. Journal of Health Communication. 20: 69-76. PMID 26513033 DOI: 10.1080/10810730.2015.1081997  1
2015 Hakimi AA, Ostrovnaya I, Jacobsen A, Susztak K, Coleman JA, Russo P, Winer AG, Mano R, Sankin AI, Motzer RJ, Voss MH, Offit K, Purdue M, Pomerantz M, Freedman M, et al. Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma. Cancer. PMID 26505625 DOI: 10.1002/cncr.29765  1
2015 Pomerantz MM, Li F, Takeda DY, Lenci R, Chonkar A, Chabot M, Cejas P, Vazquez F, Cook J, Shivdasani RA, Bowden M, Lis R, Hahn WC, Kantoff PW, Brown M, ... Freedman ML, et al. The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis. Nature Genetics. PMID 26457646 DOI: 10.1038/Ng.3419  1
2015 Munger KL, Fitzgerald KC, Freedman MS, Hartung HP, Miller DH, Montalbán X, Edan G, Barkhof F, Suarez G, Radue EW, Sandbrink R, Kappos L, Pohl C, Ascherio A. No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT. Neurology. 85: 1694-701. PMID 26453645 DOI: 10.1212/Wnl.0000000000002099  1
2015 Lawrenson K, Iversen ES, Tyrer J, Weber RP, Concannon P, Hazelett DJ, Li Q, Marks JR, Berchuck A, Lee JM, Aben KK, Anton-Culver H, Antonenkova N, ... Freedman ML, et al. Common Variants at the CHEK2 Gene Locus and Risk of Epithelial Ovarian Cancer. Carcinogenesis. PMID 26424751 DOI: 10.1093/carcin/bgv138  1
2015 Spisák S, Lawrenson K, Fu Y, Csabai I, Cottman RT, Seo JH, Haiman C, Han Y, Lenci R, Li Q, Tisza V, Szállási Z, Herbert ZT, Chabot M, Pomerantz M, ... Freedman ML, et al. CAUSEL: an epigenome- and genome-editing pipeline for establishing function of noncoding GWAS variants. Nature Medicine. PMID 26398868 DOI: 10.1038/Nm.3975  1
2015 Lawrenson K, Li Q, Kar S, Seo JH, Tyrer J, Spindler TJ, Lee J, Chen Y, Karst A, Drapkin R, Aben KK, Anton-Culver H, Antonenkova N, Baker H, ... Freedman ML, et al. Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer. Nature Communications. 6: 8234. PMID 26391404 DOI: 10.1038/Ncomms9234  0.01
2015 Linds AB, Kirstein AB, Freedman M, Verhoeff NP, Wolf U, Chow TW. Trajectories of Behavioural Disturbances Across Dementia Types. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 42: 389-94. PMID 26329453 DOI: 10.1017/cjn.2015.266  1
2015 Maza JC, McKenna JR, Raliski BK, Freedman MT, Young DD. Synthesis and Incorporation of Unnatural Amino Acids To Probe and Optimize Protein Bioconjugations. Bioconjugate Chemistry. 26: 1884-9. PMID 26287719 DOI: 10.1021/acs.bioconjchem.5b00424  1
2015 Kar SP, Tyrer JP, Li Q, Lawrenson K, Aben KK, Anton-Culver H, Antonenkova N, Chenevix-Trench G, Baker H, Bandera E, Bean YT, Beckmann MW, Berchuck A, Bisogna M, Bjørge L, ... Freedman ML, et al. Network-based integration of GWAS and gene expression identifies a HOX-centric network associated with serous ovarian cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26209509 DOI: 10.1158/1055-9965.Epi-14-1270  0.04
2015 Han Y, Hazelett DJ, Wiklund F, Schumacher FR, Stram DO, Berndt SI, Wang Z, Rand KA, Hoover RN, Machiela MJ, Yeager M, Burdette L, Chung CC, Hutchinson A, Yu K, ... Freedman ML, et al. Integration of Multiethnic Fine-mapping and Genomic Annotation to Prioritize Candidate Functional SNPs at Prostate Cancer Susceptibility Regions. Human Molecular Genetics. PMID 26162851 DOI: 10.1093/Hmg/Ddv269  1
2015 Govindarajan KA, Datta S, Hasan KM, Choi S, Rahbar MH, Cofield SS, Cutter GR, Lublin FD, Wolinsky JS, Narayana PA. Effect of in-painting on cortical thickness measurements in multiple sclerosis: A large cohort study. Human Brain Mapping. PMID 26096844 DOI: 10.1002/Hbm.22875  1
2015 Jiang P, Freedman ML, Liu JS, Liu XS. Inference of transcriptional regulation in cancers. Proceedings of the National Academy of Sciences of the United States of America. 112: 7731-6. PMID 26056275 DOI: 10.1073/pnas.1424272112  1
2015 Gaudet MM, Kitahara CM, Newton CC, Bernstein L, Reynolds P, Weiderpass E, Kreimer AR, Yang G, Adami HO, Alavanja MC, Beane Freeman LE, Boeing H, Buring J, Chaturvedi A, Chen Y, ... ... Freedman M, et al. Anthropometry and head and neck cancer:a pooled analysis of cohort data. International Journal of Epidemiology. 44: 673-81. PMID 26050257 DOI: 10.1093/Ije/Dyv059  1
2015 Hoffmann TJ, Van Den Eeden SK, Sakoda LC, Jorgenson E, Habel LA, Graff RE, Passarelli MN, Cario CL, Emami NC, Chao CR, Ghai NR, Shan J, Ranatunga DK, Quesenberry CP, Aaronson D, ... Freedman ML, et al. A Large Multiethnic Genome-Wide Association Study of Prostate Cancer Identifies Novel Risk Variants and Substantial Ethnic Differences. Cancer Discovery. PMID 26034056 DOI: 10.1158/2159-8290.Cd-15-0315  1
2015 Rush CA, MacLean HJ, Freedman MS. Aggressive multiple sclerosis: proposed definition and treatment algorithm. Nature Reviews. Neurology. 11: 379-89. PMID 26032396 DOI: 10.1038/nrneurol.2015.85  1
2015 Amin Al Olama A, Dadaev T, Hazelett DJ, Li Q, Leongamornlert D, Saunders EJ, Stephens S, Cieza-Borrella C, Whitmore I, Benlloch Garcia S, Giles GG, Southey MC, Fitzgerald L, Gronberg H, Wiklund F, ... ... Freedman M, et al. Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans. Human Molecular Genetics. PMID 26025378 DOI: 10.1093/Hmg/Ddv203  1
2015 MacMillan EL, Tam R, Zhao Y, Vavasour IM, Li D, Oger J, Freedman MS, Kolind SH, Traboulsee AL. Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26014604 DOI: 10.1177/1352458515586086  1
2015 Mahzari M, Arnaout A, Freedman MS. Alemtuzumab Induced Thyroid Disease in Multiple Sclerosis: A Review and Approach to Management. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 42: 284-91. PMID 25990097 DOI: 10.1017/cjn.2015.48  1
2015 Traboulsee A, Létourneau-Guillon L, Freedman MS, O'Connor PW, Bharatha A, Chakraborty S, Girard JM, Giuliani F, Lysack JT, Marriott JJ, Metz LM, Morrow SA, Oh J, Sharma M, Vandorpe RA, et al. Canadian Expert Panel Recommendations for MRI Use in MS Diagnosis and Monitoring. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 42: 159-67. PMID 25896163 DOI: 10.1017/cjn.2015.24  1
2015 Arem H, Moore SC, Patel A, Hartge P, Berrington de Gonzalez A, Visvanathan K, Campbell PT, Freedman M, Weiderpass E, Adami HO, Linet MS, Lee IM, Matthews CE. Leisure time physical activity and mortality: a detailed pooled analysis of the dose-response relationship. Jama Internal Medicine. 175: 959-67. PMID 25844730 DOI: 10.1001/Jamainternmed.2015.0533  1
2015 Coetzee SG, Shen HC, Hazelett DJ, Lawrenson K, Kuchenbaecker K, Tyrer J, Rhie SK, Levanon K, Karst A, Drapkin R, Ramus SJ, Couch FJ, Offit K, Chenevix-Trench G, ... ... Freedman M, et al. Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci. Human Molecular Genetics. 24: 3595-607. PMID 25804953 DOI: 10.1093/Hmg/Ddv101  1
2015 Freedman MS, Abdoli M. Evaluating response to disease-modifying therapy in relapsing multiple sclerosis. Expert Review of Neurotherapeutics. 15: 407-23. PMID 25764966 DOI: 10.1586/14737175.2015.1023711  1
2015 Freedman M, Ring M, Stassen LF. Effect of alveolar bone support on zygomatic implants in an extra-sinus position--a finite element analysis study. International Journal of Oral and Maxillofacial Surgery. 44: 785-90. PMID 25748609 DOI: 10.1016/j.ijom.2015.01.009  1
2015 Helfand BT, Roehl KA, Cooper PR, McGuire BB, Fitzgerald LM, Cancel-Tassin G, Cornu JN, Bauer S, Van Blarigan EL, Chen X, Duggan D, Ostrander EA, Gwo-Shu M, Zhang ZF, Chang SC, ... ... Freedman M, et al. Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases. Human Genetics. 134: 439-50. PMID 25715684 DOI: 10.1007/S00439-015-1534-9  1
2015 Rohrer JD, Nicholas JM, Cash DM, van Swieten J, Dopper E, Jiskoot L, van Minkelen R, Rombouts SA, Cardoso MJ, Clegg S, Espak M, Mead S, Thomas DL, De Vita E, Masellis M, ... ... Freedman M, et al. Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis. The Lancet. Neurology. 14: 253-62. PMID 25662776 DOI: 10.1016/S1474-4422(14)70324-2  1
2015 Kuchenbaecker KB, Ramus SJ, Tyrer J, Lee A, Shen HC, Beesley J, Lawrenson K, McGuffog L, Healey S, Lee JM, Spindler TJ, Lin YG, Pejovic T, Bean Y, Li Q, ... ... Freedman M, et al. Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nature Genetics. 47: 164-71. PMID 25581431 DOI: 10.1038/ng.3185  0.01
2015 Gibbs E, Karim ME, Oger J. Antibody dissociation rates are predictive of neutralizing antibody (NAb) course: a comparison of interferon beta-1b-treated Multiple Sclerosis (MS) patients with transient versus sustained NAbs. Clinical Immunology (Orlando, Fla.). 157: 91-101. PMID 25543089 DOI: 10.1016/j.clim.2014.12.005  1
2015 Penney KL, Sinnott JA, Tyekucheva S, Gerke T, Shui IM, Kraft P, Sesso HD, Freedman ML, Loda M, Mucci LA, Stampfer MJ. Association of prostate cancer risk variants with gene expression in normal and tumor tissue. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 255-60. PMID 25371445 DOI: 10.1158/1055-9965.Epi-14-0694-T  1
2015 Levaillant C, Freedman M. Interferometric versus projective measurement of anyons Leibniz International Proceedings in Informatics, Lipics. 44: 245-249. DOI: 10.4230/LIPIcs.TQC.2015.245  1
2015 Bohn S, Freedman M, Owens E. The criminal justice response to policy interventions: Evidence from immigration reform American Economic Review. 105: 214-219. DOI: 10.1257/Aer.P20151042  1
2015 Bento A, Freedman M, Lang C. Who benefits from environmental regulation? Evidence from the clean air act amendments Review of Economics and Statistics. 97: 610-622. DOI: 10.1162/Rest_A_00493  1
2015 Boschee E, Freedman M, Khanwalkar S, Kumar A, Srivastava A, Weischedel R. Researching persons & organizations: AWAKE: from text to an entity-centric knowledge base Proceedings - 2014 Ieee International Conference On Big Data, Ieee Big Data 2014. 1030-1039. DOI: 10.1109/BigData.2014.7004337  1
2015 Freedman M, Park JD, Stagliano AJ. Mandated climate change disclosures: A study of large US firms that emit carbon dioxide Advances in Public Interest Accounting. 18: 99-121. DOI: 10.1108/S1041-706020150000018003  1
2015 Dahlhaus J, Ilan R, Freed D, Freedman M, Moore JE. Pumping conductance, the intrinsic anomalous Hall effect, and statistics of topological invariants Physical Review B - Condensed Matter and Materials Physics. 91. DOI: 10.1103/Physrevb.91.245107  1
2015 Levaillant C, Bauer B, Freedman M, Wang Z, Bonderson P. Universal gates via fusion and measurement operations on SU(2)4 anyons Physical Review a - Atomic, Molecular, and Optical Physics. 92. DOI: 10.1103/Physreva.92.012301  1
2015 Freedman MR, Mirabrishami M. Vitamin C content of refrigerated, commercially available orange juice from organically grown and conventionally grown oranges is not different Nutrition Today. 50: 306-309. DOI: 10.1097/NT.0000000000000126  1
2015 Freedman MR, Hollenbeck CB, Contreras-Pena G. Hispanic Adults Attending English as a Second Language (ESL) Classes at an Adult School Are Food Insecure Journal of Hunger and Environmental Nutrition. 10: 284-292. DOI: 10.1080/19320248.2015.1004219  1
2015 Freedman MA. Potential Sites for Ice Nucleation on Aluminosilicate Clay Minerals and Related Materials Journal of Physical Chemistry Letters. 6: 3850-3858. DOI: 10.1021/acs.jpclett.5b01326  1
2015 Freedman M. Place-based programs and the geographic dispersion of employment Regional Science and Urban Economics. 53: 1-19. DOI: 10.1016/J.Regsciurbeco.2015.04.002  1
2015 Sun P, Yu M, Freedman MJ, Rexford J, Walker D. HONE: Joint Host-Network Traffic Management in Software-Defined Networks Journal of Network and Systems Management. 23: 374-399. DOI: 10.1007/S10922-014-9321-9  1
2015 Freedman M, Mcgavock T. Low-Income Housing Development, Poverty Concentration, and Neighborhood Inequality Journal of Policy Analysis and Management. 34: 805-834. DOI: 10.1002/Pam.21856  1
2015 Veghte DP, Moore JE, Jensen L, Freedman MA. Influence of shape on the optical properties of hematite aerosol Journal of Geophysical Research D: Atmospheres. DOI: 10.1002/2015Jd023160  1
2015 Ghandeharizadeh S, Balazinska M, Freedman MJ, Barahmand S. Welcome message from the socc chairs Acm Socc 2015 - Proceedings of the 6th Acm Symposium On Cloud Computing. ii.  1
2014 Freedman MS, Montalban X, Miller AE, Dive-Pouletty C, Leist TP. Assessing the Comparative Outcomes from Teriflunomide and Dimethyl Fumarate Studies in Relapsing Ms: Use of "Number Needed to Treat" Analysis. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 17: A392. PMID 27200909 DOI: 10.1016/j.jval.2014.08.864  1
2014 Hughes B, Cascione M, Freedman MS, Agius M, Kantor D, Gudesblatt M, Goldstick LP, Agashivala N, Schofield L, McCague K, Hashmonay R, Barbato L. First-dose effects of fingolimod after switching from injectable therapies in the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis. Multiple Sclerosis and Related Disorders. 3: 620-8. PMID 26265274 DOI: 10.1016/J.Msard.2014.06.006  1
2014 Stuve O, Hartung HP, Freedman M, Li D, Hemmer B, Kappos L, Rieckmann P, Montalban X, Ziemssen T, Selmaj K. Phase 2 BOLD extension study efficacy results for siponimod (BAF312) in patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis and Related Disorders. 3: 754-5. PMID 25891595 DOI: 10.1016/J.Msard.2014.09.190  1
2014 Lublin FD, Bowen JD, Huddlestone J, Kremenchutzky M, Carpenter A, Corboy JR, Freedman MS, Krupp L, Paulo C, Hariri RJ, Fischkoff SA. Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: a randomized, placebo-controlled, multiple-dose study. Multiple Sclerosis and Related Disorders. 3: 696-704. PMID 25891548 DOI: 10.1016/j.msard.2014.08.002  1
2014 Freedman MS, Comi G, De Stefano N, Barkhof F, Polman CH, Uitdehaag BM, Lehr L, Stubinski B, Kappos L. Moving toward earlier treatment of multiple sclerosis: Findings from a decade of clinical trials and implications for clinical practice. Multiple Sclerosis and Related Disorders. 3: 147-55. PMID 25878002 DOI: 10.1016/J.Msard.2013.07.001  1
2014 Walker LA, Berard JA, Atkins HL, Bowman M, Lee H, Freedman MS. Cognitive change and neuroimaging following immunoablative therapy and hematopoietic stem cell transplantation in multiple sclerosis: A pilot study. Multiple Sclerosis and Related Disorders. 3: 129-35. PMID 25877984 DOI: 10.1016/j.msard.2013.05.001  1
2014 Bhan V, Lapierre Y, Freedman MS, Duquette P, Selchen D, Migounov V, Walt L, Zhang A. Anti-JC Virus Antibody Prevalence in Canadian MS Patients. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 41: 748-52. PMID 25377521 DOI: 10.1017/cjn.2014.32  1
2014 Freedman MS. Evidence for the efficacy of interferon beta-1b in delaying the onset of clinically definite multiple sclerosis in individuals with clinically isolated syndrome. Therapeutic Advances in Neurological Disorders. 7: 279-88. PMID 25371710 DOI: 10.1177/1756285614549554  1
2014 Marcotte K, Graham NL, Black SE, Tang-Wai D, Chow TW, Freedman M, Rochon E, Leonard C. Verb production in the nonfluent and semantic variants of primary progressive aphasia: the influence of lexical and semantic factors. Cognitive Neuropsychology. 31: 565-83. PMID 25358022 DOI: 10.1080/02643294.2014.970154  1
2014 Munger KL, Köchert K, Simon KC, Kappos L, Polman CH, Freedman MS, Hartung HP, Miller DH, Montalbán X, Edan G, Barkhof F, Pleimes D, Sandbrink R, Ascherio A, Pohl C. Molecular mechanism underlying the impact of vitamin D on disease activity of MS. Annals of Clinical and Translational Neurology. 1: 605-17. PMID 25285313 DOI: 10.1002/Acn3.91  1
2014 Freedman MA. Perceptions of dyspareunia in postmenopausal women with vulvar and vaginal atrophy: findings from the REVIVE survey. Women's Health (London, England). 10: 445-54. PMID 25259904 DOI: 10.2217/whe.14.29  1
2014 Al Olama AA, Kote-Jarai Z, Berndt SI, Conti DV, Schumacher F, Han Y, Benlloch S, Hazelett DJ, Wang Z, Saunders E, Leongamornlert D, Lindstrom S, Jugurnauth-Little S, Dadaev T, Tymrakiewicz M, ... ... Freedman ML, et al. A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer. Nature Genetics. 46: 1103-9. PMID 25217961 DOI: 10.1038/Ng.3094  0.01
2014 Sihvonen SK, Schill GP, Lyktey NA, Veghte DP, Tolbert MA, Freedman MA. Chemical and physical transformations of aluminosilicate clay minerals due to acid treatment and consequences for heterogeneous ice nucleation. The Journal of Physical Chemistry. A. 118: 8787-96. PMID 25211030 DOI: 10.1021/Jp504846G  1
2014 Miller AE, Wolinsky JS, Kappos L, Comi G, Freedman MS, Olsson TP, Bauer D, Benamor M, Truffinet P, O'Connor PW. Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet. Neurology. 13: 977-86. PMID 25192851 DOI: 10.1016/S1474-4422(14)70191-7  1
2014 Portman DJ, Gass MLS, Kingsberg S, Archer D, Bachmann G, Burrows L, Freedman M, Goldstein A, Goldstein I, Heller D, Iglesia CB, Kagan R, Spadt SK, Krychman M, Nachtigall L, et al. Genitourinary syndrome of menopause: New terminology for vulvovaginal atrophy from the international society for the study of women's sexual health and the North American Menopause Society Menopause. 21: 1063-1068. PMID 25160739 DOI: 10.1097/gme.0000000000000329  0.01
2014 Mattson CL, Freedman M, Fagan JL, Frazier EL, Beer L, Huang P, Valverde EE, Johnson C, Sanders C, McNaghten AD, Sullivan P, Lansky A, Mermin J, Heffelfinger J, Skarbinski J, et al. Sexual risk behaviour and viral suppression among HIV-infected adults receiving medical care in the United States. Aids (London, England). 28: 1203-11. PMID 25000558 DOI: 10.1097/QAD.0000000000000273  1
2014 Miller AE, Macdonell R, Comi G, Freedman MS, Kappos L, Mäurer M, Olsson TP, Wolinsky JS, Bozzi S, Dive-Pouletty C, O'Connor PW. Teriflunomide reduces relapses with sequelae and relapses leading to hospitalizations: results from the TOWER study. Journal of Neurology. 261: 1781-8. PMID 24972678 DOI: 10.1007/s00415-014-7395-7  1
2014 Freedman MS. Efficacy and safety of subcutaneous interferon-β-1a in patients with a first demyelinating event and early multiple sclerosis. Expert Opinion On Biological Therapy. 14: 1207-14. PMID 24965353 DOI: 10.1517/14712598.2014.924496  1
2014 Freedman M, Alladi S, Chertkow H, Bialystok E, Craik FI, Phillips NA, Duggirala V, Raju SB, Bak TH. Delaying onset of dementia: are two languages enough? Behavioural Neurology. 2014: 808137. PMID 24959001 DOI: 10.1155/2014/808137  1
2014 Blair JM, Fagan JL, Frazier EL, Do A, Bradley H, Valverde EE, McNaghten A, Beer L, Zhang S, Huang P, Mattson CL, Freedman MS, Johnson CH, Sanders CC, Spruit-McGoff KE, et al. Behavioral and clinical characteristics of persons receiving medical care for HIV infection - Medical Monitoring Project, United States, 2009. Morbidity and Mortality Weekly Report. Surveillance Summaries (Washington, D.C. : 2002). 63: 1-22. PMID 24941443  1
2014 Li Q, Stram A, Chen C, Kar S, Gayther S, Pharoah P, Haiman C, Stranger B, Kraft P, Freedman ML. Expression QTL-based analyses reveal candidate causal genes and loci across five tumor types. Human Molecular Genetics. 23: 5294-302. PMID 24907074 DOI: 10.1093/Hmg/Ddu228  1
2014 Freedman MS. Multiple sclerosis: Does aggressive MS warrant aggressive treatment? Nature Reviews. Neurology. 10: 368-70. PMID 24890645 DOI: 10.1038/nrneurol.2014.98  1
2014 Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Barkhof F, Bebo B, Calabresi PA, Clanet M, Comi G, Fox RJ, ... Freedman MS, et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 83: 278-86. PMID 24871874 DOI: 10.1212/Wnl.0000000000000560  1
2014 Freedman M, Greis AC, Marino L, Sinha AN, Henstenburg J. Complex regional pain syndrome: diagnosis and treatment. Physical Medicine and Rehabilitation Clinics of North America. 25: 291-303. PMID 24787334 DOI: 10.1016/j.pmr.2014.01.003  1
2014 Sartori A, Carle D, Freedman MS. Teriflunomide: a novel oral treatment for relapsing multiple sclerosis. Expert Opinion On Pharmacotherapy. 15: 1019-27. PMID 24742277 DOI: 10.1517/14656566.2014.902936  1
2014 Do AN, Rosenberg ES, Sullivan PS, Beer L, Strine TW, Schulden JD, Fagan JL, Freedman MS, Skarbinski J. Excess burden of depression among HIV-infected persons receiving medical care in the united states: data from the medical monitoring project and the behavioral risk factor surveillance system. Plos One. 9: e92842. PMID 24663122 DOI: 10.1371/Journal.Pone.0092842  1
2014 Olsson T, Boster A, Fernández Ó, Freedman MS, Pozzilli C, Bach D, Berkani O, Mueller MS, Sidorenko T, Radue EW, Melanson M. Oral ponesimod in relapsing-remitting multiple sclerosis: a randomised phase II trial. Journal of Neurology, Neurosurgery, and Psychiatry. 85: 1198-208. PMID 24659797 DOI: 10.1136/jnnp-2013-307282  0.01
2014 Kappos L, Hartung HP, Freedman MS, Boyko A, Radü EW, Mikol DD, Lamarine M, Hyvert Y, Freudensprung U, Plitz T, van Beek J. Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial. The Lancet. Neurology. 13: 353-63. PMID 24613349 DOI: 10.1016/S1474-4422(14)70028-6  1
2014 Correale J, Abad P, Alvarenga R, Alves-Leon S, Armas E, Barahona J, Buzó R, Corona T, Cristiano E, Gracia F, Bonitto JG, Macías MA, Soto A, Vizcarra D, Freedman MS. Management of relapsing-remitting multiple sclerosis in Latin America: practical recommendations for treatment optimization. Journal of the Neurological Sciences. 339: 196-206. PMID 24607335 DOI: 10.1016/j.jns.2014.02.017  1
2014 Shi J, Marconett CN, Duan J, Hyland PL, Li P, Wang Z, Wheeler W, Zhou B, Campan M, Lee DS, Huang J, Zhou W, Triche T, Amundadottir L, Warner A, ... ... Freedman M, et al. Characterizing the genetic basis of methylome diversity in histologically normal human lung tissue. Nature Communications. 5: 3365. PMID 24572595 DOI: 10.1038/Ncomms4365  1
2014 Leist TP, Comi G, Cree BA, Coyle PK, Freedman MS, Hartung HP, Vermersch P, Casset-Semanaz F, Scaramozza M. Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial. The Lancet. Neurology. 13: 257-67. PMID 24502830 DOI: 10.1016/S1474-4422(14)70005-5  1
2014 Veghte DP, Bittner DR, Freedman MA. Cryo-transmission electron microscopy imaging of the morphology of submicrometer aerosol containing organic acids and ammonium sulfate. Analytical Chemistry. 86: 2436-42. PMID 24502281 DOI: 10.1021/Ac403279F  1
2014 Confavreux C, O'Connor P, Comi G, Freedman MS, Miller AE, Olsson TP, Wolinsky JS, Bagulho T, Delhay JL, Dukovic D, Truffinet P, Kappos L. Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet. Neurology. 13: 247-56. PMID 24461574 DOI: 10.1016/S1474-4422(13)70308-9  1
2014 Ascherio A, Munger KL, White R, Köchert K, Simon KC, Polman CH, Freedman MS, Hartung HP, Miller DH, Montalbán X, Edan G, Barkhof F, Pleimes D, Radü EW, Sandbrink R, et al. Vitamin D as an early predictor of multiple sclerosis activity and progression. Jama Neurology. 71: 306-14. PMID 24445558 DOI: 10.1001/Jamaneurol.2013.5993  1
2014 Berrigan LI, Fisk JD, Walker LA, Wojtowicz M, Rees LM, Freedman MS, Marrie RA. Reliability of regression-based normative data for the oral symbol digit modalities test: an evaluation of demographic influences, construct validity, and impairment classification rates in multiple sclerosis samples. The Clinical Neuropsychologist. 28: 281-99. PMID 24438521 DOI: 10.1080/13854046.2013.871337  1
2014 Freedman MS, De Stefano N, Barkhof F, Polman CH, Comi G, Uitdehaag BM, Casset-Semanaz F, Hennessy B, Lehr L, Stubinski B, Jack DL, Kappos L. Patient subgroup analyses of the treatment effect of subcutaneous interferon β-1a on development of multiple sclerosis in the randomized controlled REFLEX study. Journal of Neurology. 261: 490-9. PMID 24413638 DOI: 10.1007/S00415-013-7222-6  1
2014 De Stefano N, Comi G, Kappos L, Freedman MS, Polman CH, Uitdehaag BM, Hennessy B, Casset-Semanaz F, Lehr L, Stubinski B, Jack DL, Barkhof F. Efficacy of subcutaneous interferon β-1a on MRI outcomes in a randomised controlled trial of patients with clinically isolated syndromes. Journal of Neurology, Neurosurgery, and Psychiatry. 85: 647-53. PMID 24292999 DOI: 10.1136/Jnnp-2013-306289  1
2014 Bialystok E, Craik FI, Binns MA, Ossher L, Freedman M. Effects of bilingualism on the age of onset and progression of MCI and AD: evidence from executive function tests. Neuropsychology. 28: 290-304. PMID 24245925 DOI: 10.1037/Neu0000023  1
2014 Freedman MS. Treatment options for patients with multiple sclerosis who have a suboptimal response to interferon-β therapy. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 21: 377-87, e18-20. PMID 24237582 DOI: 10.1111/ene.12299  1
2014 Al Tahan AM, Alsharoqi I, Bohlega SA, Dahdaleh M, Daif A, Deleu D, Esmat K, Giampaolo D, Freedman MS, Gwilt M, Hosny H, Inshasi JS, Aljumah M, Khalifa A, Pakdaman H, et al. Characteristics of multiple sclerosis in the Middle East with special reference to the applicability of international guidelines to the region. The International Journal of Neuroscience. 124: 635-41. PMID 24228830 DOI: 10.3109/00207454.2013.865620  1
2014 Edan G, Kappos L, Montalbán X, Polman CH, Freedman MS, Hartung HP, Miller D, Barkhof F, Herrmann J, Lanius V, Stemper B, Pohl C, Sandbrink R, Pleimes D. Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT. Journal of Neurology, Neurosurgery, and Psychiatry. 85: 1183-9. PMID 24218527 DOI: 10.1136/Jnnp-2013-306222  1
2014 Berard JA, Bowman M, Atkins HL, Freedman MS, Walker LA. Cognitive fatigue in individuals with multiple sclerosis undergoing immunoablative therapy and hematopoietic stem cell transplantation. Journal of the Neurological Sciences. 336: 132-7. PMID 24189209 DOI: 10.1016/j.jns.2013.10.023  1
2014 Vermersch P, Czlonkowska A, Grimaldi LM, Confavreux C, Comi G, Kappos L, Olsson TP, Benamor M, Bauer D, Truffinet P, Church M, Miller AE, Wolinsky JS, Freedman MS, O'Connor P, et al. Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 705-16. PMID 24126064 DOI: 10.1177/1352458513507821  1
2014 Nagtegaal GJ, Pohl C, Wattjes MP, Hulst HE, Freedman MS, Hartung HP, Miller D, Montalban X, Kappos L, Edan G, Pleimes D, Beckman K, Stemper B, Polman CH, Sandbrink R, et al. Interferon beta-1b reduces black holes in a randomised trial of clinically isolated syndrome. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 234-42. PMID 23842212 DOI: 10.1177/1352458513494491  1
2014 Furlan JC, Henri-Bhargava A, Freedman M. Clomipramine in the treatment of compulsive behavior in frontotemporal dementia: a case series. Alzheimer Disease and Associated Disorders. 28: 95-8. PMID 22892646 DOI: 10.1097/WAD.0b013e318265c104  1
2014 Anderson T, Birman K, Broberg R, Caesar M, Comer D, Cotton C, Freedman MJ, Haeberlen A, Ives ZG, Krishnamurthy A, Lehr W, Loo BT, Mazières D, Nicolosi A, Smith JM, et al. A brief overview of the NEBULA future internet architecture Computer Communication Review. 44: 81-86. DOI: 10.1145/2656877.2656889  1
2014 Lloyd W, Freedman MJ, Kaminsky M, Andersen DG. Stronger properties for low-latency geo-replicated storage Queue. 12. DOI: 10.1145/2602649.2610533  1
2014 Lloyd W, Freedman MJ, Kaminsky M, Andersen DG. Don't settle for eventual consistency Communications of the Acm. 57: 61-68. DOI: 10.1145/2596624  1
2014 Shue D, Freedman MJ. From application requests to virtual IOPs: Provisioned key-value storage with libra Proceedings of the 9th European Conference On Computer Systems, Eurosys 2014. DOI: 10.1145/2592798.2592823  1
2014 Li X, Andersen DG, Kaminsky M, Freedman MJ. Algorithmic improvements for fast concurrent cuckoo hashing Proceedings of the 9th European Conference On Computer Systems, Eurosys 2014. DOI: 10.1145/2592798.2592820  1
2014 Blankstein A, Freedman MJ. Automating isolation and least privilege in web services Proceedings - Ieee Symposium On Security and Privacy. 133-148. DOI: 10.1109/SP.2014.16  1
2014 Freedman M, Jaggi B. Editors' introduction Advances in Environmental Accounting and Management. 5: xiii-xvi. DOI: 10.1108/S1479-359820145  1
2014 Cong Y, Freedman M, Park JD. Measuring environmental performance: Is Newsweek's Green Ranking the solution? Advances in Environmental Accounting and Management. 5: 49-79. DOI: 10.1108/S1479-359820140000005011  1
2014 Freedman M, Kosová R. Agency and compensation: Evidence from the hotel industry Journal of Law, Economics, and Organization. 30: 72-103. DOI: 10.1093/jleo/ews027  1
2014 Freedman M, Park JD. Mandated climate change disclosures by firms participating in the regional greenhouse gas initiative Social and Environmental Accountability Journal. 34: 29-44. DOI: 10.1080/0969160X.2013.852988  1
2014 Veghte DP, Freedman MA. Facile method for determining the aspect ratios of mineral dust aerosol by electron microscopy Aerosol Science and Technology. 48: 715-724. DOI: 10.1080/02786826.2014.920484  1
2014 Portman DJ, Gass MLS. Genitourinary syndrome of menopause: New terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society Maturitas. DOI: 10.1016/j.maturitas.2014.07.013  0.01
2014 Freedman M, Kaner O, Kaplan I. Voting for extreme right parties in Israel: Evidence from the 2009 elections Electoral Studies. 34: 68-77. DOI: 10.1016/J.Electstud.2013.09.011  1
2014 Cong Y, Freedman M, Park JD. Tone at the top: CEO environmental rhetoric and environmental performance Advances in Accounting. 30: 322-327. DOI: 10.1016/j.adiac.2014.09.007  1
2014 Freedman M, Krushkal V. Geometric complexity of embeddings in Rd Geometric and Functional Analysis. 24: 1406-1430. DOI: 10.1007/s00039-014-0272-9  1
2014 Khoshnam M, Freedman M. Relapsing MS: Disease Staging and Therapeutic Algorithms Multiple Sclerosis and Cns Inflammatory Disorders. 45-56. DOI: 10.1002/9781118298633.ch5  1
2014 Svore KM, Hastings MB, Freedman M. Faster phase estimation Quantum Information and Computation. 14: 306-328.  1
2014 Freedman M, Burke MG. Journal Club: Narrow-spectrum and broad-spectrum antibiotics effective for inpatient pneumonia Contemporary Pediatrics. 31: 30-31.  1
2014 Freedman M, Burke MG. Monovalent rotavirus vaccine elevates intussusception risk Contemporary Pediatrics. 31.  1
2014 Freedman M. Treatment of choice for Rocky Mountain spotted fever Contemporary Pediatrics. 31.  1
2014 Freedman M, Burke MG. Procalcitonin predicts bacterial coinfection in acute bronchiolitis Contemporary Pediatrics. 31.  1
2014 Freedman M. The key to vaccine-hesitant parents Contemporary Pediatrics. 31.  1
2014 Freedman MH, Hastings MB. Quantum systems on non-k-hyperfinite complexes: A generalization of classical statistical mechanics on expander graphs Quantum Information and Computation. 14: 144-180.  1
2014 Freedman M, Burke MG. Sexuality talk gets short shrift at teen health maintenance visits Contemporary Pediatrics. 31.  1
2014 Freedman M, Burke MG. Tobacco smoke exposure tied to readmission in asthmatics Contemporary Pediatrics. 31.  1
2014 Freedman M, Burke MG. What is the best way to treat tympanostomy tube otorrhea? Contemporary Pediatrics. 31.  1
2014 Freedman M, Burke MG. Screening rule differentiates between vasovagal and cardiac syncope Contemporary Pediatrics. 31.  1
2014 Freedman M. Impact of restrictions on teenaged tanning Contemporary Pediatrics. 31.  1
2014 Freedman M, Burke MG. New tool helps monitor asthma symptoms Contemporary Pediatrics. 31.  1
2014 Freedman M, Burke MG. Short-course treatment for outpatient pneumonia-how long should it be? Contemporary Pediatrics. 31.  1
2014 Freedman M. Kingella kingae osteoarticular infections Contemporary Pediatrics. 31.  1
2014 Freedman M, Burke MG. Casino-related economic increase is linked to obesity risk decrease Contemporary Pediatrics. 31.  1
2014 Freedman M, Burke MG. Year's 10 most helpful articles Contemporary Pediatrics. 31.  1
2014 Freedman M, Burke MG. Office-based parent training reduces disruptive toddler behavior Contemporary Pediatrics. 31.  1
2014 Freedman M, Burke MG. Iron supplementation is effective treatment for restless leg syndrome Contemporary Pediatrics. 31.  1
2014 Freedman M, Burke MG. Insights into racial differences in vitamin D levels Contemporary Pediatrics. 31.  1
2013 Freedman MS, Kaplan JM, Markovic-Plese S. Insights into the Mechanisms of the Therapeutic Efficacy of Alemtuzumab in Multiple Sclerosis. Journal of Clinical & Cellular Immunology. 4. PMID 24363961 DOI: 10.4172/2155-9899.1000152  0.01
2013 Nan H, Morikawa T, Suuriniemi M, Imamura Y, Werner L, Kuchiba A, Yamauchi M, Hunter DJ, Kraft P, Giovannucci EL, Fuchs CS, Ogino S, Freedman ML, Chan AT. Aspirin use, 8q24 single nucleotide polymorphism rs6983267, and colorectal cancer according to CTNNB1 alterations. Journal of the National Cancer Institute. 105: 1852-61. PMID 24317174 DOI: 10.1093/jnci/djt331  1
2013 Freedman M, Stassen LF. Commonly used topical oral wound dressing materials in dental and surgical practice--a literature review. Journal of the Irish Dental Association. 59: 190-5. PMID 24156211  1
2013 Monteiro AN, Freedman ML. Lessons from postgenome-wide association studies: functional analysis of cancer predisposition loci. Journal of Internal Medicine. 274: 414-24. PMID 24127939 DOI: 10.1111/joim.12085  1
2013 Veghte DP, Altaf MB, Freedman MA. Size dependence of the structure of organic aerosol. Journal of the American Chemical Society. 135: 16046-9. PMID 24125549 DOI: 10.1021/Ja408903G  1
2013 Hildick-Smith GJ, Cooney JD, Garone C, Kremer LS, Haack TB, Thon JN, Miyata N, Lieber DS, Calvo SE, Akman HO, Yien YY, Huston NC, Branco DS, Shah DI, Freedman ML, et al. Macrocytic anemia and mitochondriopathy resulting from a defect in sideroflexin 4. American Journal of Human Genetics. 93: 906-14. PMID 24119684 DOI: 10.1016/J.Ajhg.2013.09.011  1
2013 Anderson BJ, Freedman MB, Millikan SP, Jasinski JP. 2-[1-(2-Hy-droxy-4-meth-oxy-phen-yl)ethyl-idene]-N-methyl-hydrazinecarbo-thio-amide. Acta Crystallographica. Section E, Structure Reports Online. 69: o1315. PMID 24109389 DOI: 10.1107/S1600536813019831  1
2013 Freedman MS. Teriflunomide in relapsing multiple sclerosis: therapeutic utility. Therapeutic Advances in Chronic Disease. 4: 192-205. PMID 23997924 DOI: 10.1177/2040622313492810  1
2013 Day GS, Farb NA, Tang-Wai DF, Masellis M, Black SE, Freedman M, Pollock BG, Chow TW. Salience network resting-state activity: prediction of frontotemporal dementia progression. Jama Neurology. 70: 1249-53. PMID 23959214 DOI: 10.1001/Jamaneurol.2013.3258  1
2013 Petrick N, Sahiner B, Armato SG, Bert A, Correale L, Delsanto S, Freedman MT, Fryd D, Gur D, Hadjiiski L, Huo Z, Jiang Y, Morra L, Paquerault S, Raykar V, et al. Evaluation of computer-aided detection and diagnosis systems. Medical Physics. 40: 087001. PMID 23927365 DOI: 10.1118/1.4816310  1
2013 Freedman MS. Present and emerging therapies for multiple sclerosis. Continuum (Minneapolis, Minn.). 19: 968-91. PMID 23917096 DOI: 10.1212/01.CON.0000433288.30715.e3  1
2013 Berrigan LI, Lefevre JA, Rees LM, Berard J, Freedman MS, Walker LA. Cognition in early relapsing-remitting multiple sclerosis: consequences may be relative to working memory. Journal of the International Neuropsychological Society : Jins. 19: 938-49. PMID 23866100 DOI: 10.1017/S1355617713000696  1
2013 O'Connor PW, Lublin FD, Wolinsky JS, Confavreux C, Comi G, Freedman MS, Olsson TP, Miller AE, Dive-Pouletty C, Bégo-Le-Bagousse G, Kappos L. Teriflunomide reduces relapse-related neurological sequelae, hospitalizations and steroid use. Journal of Neurology. 260: 2472-80. PMID 23852658 DOI: 10.1007/s00415-013-6979-y  1
2013 Bar-Or A, Freedman MS, Kremenchutzky M, Menguy-Vacheron F, Bauer D, Jodl S, Truffinet P, Benamor M, Chambers S, O'Connor PW. Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis. Neurology. 81: 552-8. PMID 23851964 DOI: 10.1212/WNL.0b013e31829e6fbf  1
2013 Huo Z, Summers RM, Paquerault S, Lo J, Hoffmeister J, Armato SG, Freedman MT, Lin J, Lo SC, Petrick N, Sahiner B, Fryd D, Yoshida H, Chan HP. Quality assurance and training procedures for computer-aided detection and diagnosis systems in clinical use. Medical Physics. 40: 077001. PMID 23822459 DOI: 10.1118/1.4807642  1
2013 Grand'Maison F, Bhan V, Freedman MS, Myles ML, Patry DG, Selchen DH, Moriarty P, Traboulsee AL. Utility of the Canadian Treatment Optimization Recommendations (TOR) in MS care. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 40: 527-35. PMID 23786735  1
2013 Selmaj K, Li DK, Hartung HP, Hemmer B, Kappos L, Freedman MS, Stüve O, Rieckmann P, Montalban X, Ziemssen T, Auberson LZ, Pohlmann H, Mercier F, Dahlke F, Wallström E. Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study. The Lancet. Neurology. 12: 756-67. PMID 23764350 DOI: 10.1016/S1474-4422(13)70102-9  1
2013 Menon S, Shirani A, Zhao Y, Oger J, Traboulsee A, Freedman MS, Tremlett H. Characterising aggressive multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 84: 1192-8. PMID 23744892 DOI: 10.1136/Jnnp-2013-304951  1
2013 Seo JH, Li Q, Fatima A, Eklund A, Szallasi Z, Polyak K, Richardson AL, Freedman ML. Deconvoluting complex tissues for expression quantitative trait locus-based analyses. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 368: 20120363. PMID 23650637 DOI: 10.1098/rstb.2012.0363  1
2013 Pomerantz M, Freedman ML. Clinical uncertainty of prostate cancer genetic risk panels. Science Translational Medicine. 5: 182ed6. PMID 23616119 DOI: 10.1126/scitranslmed.3004696  1
2013 Freedman M, Binns MA, Black SE, Levine B, Miller BL, Ramirez J, Szilagyi GM, Scott CJ, McNeely AA, Stuss DT. Object alternation: a novel probe of medial frontal function in frontotemporal dementia. Alzheimer Disease and Associated Disorders. 27: 316-23. PMID 23604006 DOI: 10.1097/Wad.0B013E318293B546  1
2013 Freedman MS, Selchen D, Arnold DL, Prat A, Banwell B, Yeung M, Morgenthau D, Lapierre Y. Treatment optimization in MS: Canadian MS Working Group updated recommendations. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 40: 307-23. PMID 23603165 DOI: 10.1017/S0317167100014244  1
2013 Radcliff K, Freedman M, Hilibrand A, Isaac R, Lurie JD, Zhao W, Vaccaro A, Albert T, Weinstein JN. Does opioid pain medication use affect the outcome of patients with lumbar disc herniation? Spine. 38: E849-60. PMID 23591657 DOI: 10.1097/BRS.0b013e3182959e4e  1
2013 Mehnert MJ, Freedman MK. Update on the role of z-joint injection and radiofrequency neurotomy for cervicogenic headache. Pm & R : the Journal of Injury, Function, and Rehabilitation. 5: 221-7. PMID 23481329 DOI: 10.1016/j.pmrj.2013.01.001  0.01
2013 Darlington PJ, Touil T, Doucet JS, Gaucher D, Zeidan J, Gauchat D, Corsini R, Kim HJ, Duddy M, Jalili F, Arbour N, Kebir H, Chen J, Arnold DL, Bowman M, ... ... Freedman MS, et al. Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation. Annals of Neurology. 73: 341-54. PMID 23463494 DOI: 10.1002/Ana.23784  1
2013 Wolinsky JS, Narayana PA, Nelson F, Datta S, O'Connor P, Confavreux C, Comi G, Kappos L, Olsson TP, Truffinet P, Wang L, Miller A, Freedman MS. Magnetic resonance imaging outcomes from a phase III trial of teriflunomide. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 1310-9. PMID 23447359 DOI: 10.1177/1352458513475723  1
2013 Chen C, Garcia-Santos D, Ishikawa Y, Seguin A, Li L, Fegan KH, Hildick-Smith GJ, Shah DI, Cooney JD, Chen W, King MJ, Yien YY, Schultz IJ, Anderson H, Dalton AJ, ... Freedman ML, et al. Snx3 regulates recycling of the transferrin receptor and iron assimilation. Cell Metabolism. 17: 343-52. PMID 23416069 DOI: 10.1016/J.Cmet.2013.01.013  1
2013 Li Q, Seo JH, Stranger B, McKenna A, Pe'er I, Laframboise T, Brown M, Tyekucheva S, Freedman ML. Integrative eQTL-based analyses reveal the biology of breast cancer risk loci. Cell. 152: 633-41. PMID 23374354 DOI: 10.1016/J.Cell.2012.12.034  1
2013 Freedman M, Ring M, Stassen LF. Effect of alveolar bone support on zygomatic implants: a finite element analysis study. International Journal of Oral and Maxillofacial Surgery. 42: 671-6. PMID 23347879 DOI: 10.1016/j.ijom.2012.12.006  1
2013 McNaghten AD, Valverde EE, Blair JM, Johnson CH, Freedman MS, Sullivan PS. Routine HIV testing among providers of HIV care in the United States, 2009. Plos One. 8: e51231. PMID 23341880 DOI: 10.1371/journal.pone.0051231  1
2013 Murray TJ, Bray G, Freedman M, Stoessl AJ. Neurology in Canada: history of the Canadian Neurological Society. Neurology. 80: 406-8. PMID 23339206 DOI: 10.1212/WNL.0b013e31827f0788  1
2013 Lam B, Masellis M, Freedman M, Stuss DT, Black SE. Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome. Alzheimer's Research & Therapy. 5: 1. PMID 23302773 DOI: 10.1186/Alzrt155  1
2013 Schutz FA, Pomerantz MM, Gray KP, Atkins MB, Rosenberg JE, Hirsch MS, McDermott DF, Lampron ME, Lee GS, Signoretti S, Kantoff PW, Freedman ML, Choueiri TK. Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study. The Lancet. Oncology. 14: 81-7. PMID 23219378 DOI: 10.1016/S1470-2045(12)70517-X  1
2013 Atkins HL, Freedman MS. Hematopoietic stem cell therapy for multiple sclerosis: top 10 lessons learned. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 10: 68-76. PMID 23192675 DOI: 10.1007/s13311-012-0162-5  1
2013 Uccelli A, Laroni A, Freedman MS. Mesenchymal stem cells as treatment for MS - progress to date. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 515-9. PMID 23124791 DOI: 10.1177/1352458512464686  1
2013 Farb NA, Grady CL, Strother S, Tang-Wai DF, Masellis M, Black S, Freedman M, Pollock BG, Campbell KL, Hasher L, Chow TW. Abnormal network connectivity in frontotemporal dementia: evidence for prefrontal isolation. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 49: 1856-73. PMID 23092697 DOI: 10.1016/J.Cortex.2012.09.008  1
2013 Freedman M, Binns MA, Black SE, Murphy C, Stuss DT. Theory of mind and recognition of facial emotion in dementia: challenge to current concepts. Alzheimer Disease and Associated Disorders. 27: 56-61. PMID 22407224 DOI: 10.1097/Wad.0B013E31824Ea5Db  1
2013 Baustian KJ, Wise ME, Jensen EJ, Schill GP, Freedman MA, Tolbert MA. State transformations and ice nucleation in amorphous (semi-)solid organic aerosol Atmospheric Chemistry and Physics. 13: 5615-5628. DOI: 10.5194/Acp-13-5615-2013  1
2013 Freedman M, Park JD, Romero J. Recognizing environmental liabilities surrounding CEO turnovers Advances in Public Interest Accounting. 16: 117-143. DOI: 10.1108/S1041-7060(2013)0000016008  1
2013 Freedman MR, Bartoli C. Food Intake Patterns and Plate Waste Among Community Meal Center Guests Show Room for Improvement Journal of Hunger and Environmental Nutrition. 8: 506-515. DOI: 10.1080/19320248.2013.787380  1
2013 Kappos L, Edan G, Freedman M, Montalbán X, Miller D, Polman C, Hartung H-, Hemmer B, Fox E, Barkhof F, Schippling S, Lanius V, Hermann J, Pohl C, Sandbrink R, et al. Benefit 11: Long-term follow-up study of patients with clinically isolated syndrome treated with interferon beta-1b Journal of the Neurological Sciences. 333. DOI: 10.1016/J.Jns.2013.07.1391  1
2013 Freedman M, Burke MG. Journal club:Driving distractions especially risky for teens with ADHD Contemporary Pediatrics. 30: 21-22.  1
2013 Freedman M, Burke MG. Kids consume sugary drinks because they're available, affordable Contemporary Pediatrics. 30: 24-26.  1
2013 Freedman MJ. Novels we missed Aba Journal. 98.  1
2013 Freedman M. Targeted business incentives and local labor markets Journal of Human Resources. 48: 311-344.  1
2012 Cruce R, Vosoughi R, Freedman MS. Cognitive impact of anticholinergic medication in MS: Adding insult to injury? Multiple Sclerosis and Related Disorders. 1: 156-61. PMID 25877263 DOI: 10.1016/j.msard.2012.05.002  1
2012 Walker LA, Cheng A, Berard J, Berrigan LI, Rees LM, Freedman MS. Tests of information processing speed: what do people with multiple sclerosis think about them? International Journal of Ms Care. 14: 92-9. PMID 24453739 DOI: 10.7224/1537-2073-14.2.92  1
2012 Brown RD, Tong Q, Becker JS, Freedman MA, Yufa NA, Sibener SJ. Dynamics of molecular and polymeric interfaces probed with atomic beam scattering and scanning probe imaging. Faraday Discussions. 157: 307-23; discussion 3. PMID 23230775 DOI: 10.1039/C2Fd20016C  1
2012 Selchen D, Bhan V, Blevins G, Devonshire V, Duquette P, Grand'Maison F, Kremenchutzky M, Lapierre Y, Li D, von Riedemann SJ, Freedman M. MS, MRI, and the 2010 McDonald criteria: a Canadian expert commentary. Neurology. 79: S1-15. PMID 23212280 DOI: 10.1212/Wnl.0B013E318277D144  1
2012 Ferruzzi MG, Peterson DG, Singh RP, Schwartz SJ, Freedman MR. Nutritional translation blended with food science: 21st century applications. Advances in Nutrition (Bethesda, Md.). 3: 813-9. PMID 23153735 DOI: 10.3945/An.112.003202  1
2012 Costello F, Hodge W, Pan YI, Burton JM, Freedman MS, Stys PK, Trufyn J, Kardon R. Sex-specific differences in retinal nerve fiber layer thinning after acute optic neuritis. Neurology. 79: 1866-72. PMID 23077012 DOI: 10.1212/WNL.0b013e318271f755  1
2012 Veghte DP, Freedman MA. The necessity of microscopy to characterize the optical properties of size-selected, nonspherical aerosol particles. Analytical Chemistry. 84: 9101-8. PMID 23043640 DOI: 10.1021/Ac3017373  1
2012 Khoshnam M, Freedman MS. Disease-specific therapy of idiopathic inflammatory demyelinating disorders. Expert Review of Neurotherapeutics. 12: 1113-24. PMID 23039390 DOI: 10.1586/ern.12.101  1
2012 Freedman M, Helber G, Pothast J, Shahwan TG, Simon J, Sher L. Electrodiagnostic evaluation of compressive nerve injuries of the upper extremities. The Orthopedic Clinics of North America. 43: 409-16. PMID 23026456 DOI: 10.1016/j.ocl.2012.07.010  0.01
2012 Freedman MR. Real-world nutritional translation blended with food science. Advances in Nutrition (Bethesda, Md.). 3: 741-3. PMID 22983861 DOI: 10.3945/an.112.002709  0.01
2012 Freedman M. The use of natalizumab for treatment of MS: do the risks still outweigh the gains? The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 39: 559-60. PMID 22931689 DOI: 10.1017/S0317167100015213  0.01
2012 Greene DN, Schmidt RL, Wilson AR, Freedman MS, Grenache DG. Cerebrospinal fluid myelin basic protein is frequently ordered but has little value: a test utilization study. American Journal of Clinical Pathology. 138: 262-72. PMID 22904139 DOI: 10.1309/AJCPCYCH96QYPHJM  1
2012 Dwyer JT, Fulgoni VL, Clemens RA, Schmidt DB, Freedman MR. Is "processed" a four-letter word? The role of processed foods in achieving dietary guidelines and nutrient recommendations. Advances in Nutrition (Bethesda, Md.). 3: 536-48. PMID 22797990 DOI: 10.3945/An.111.000901  1
2012 Grisanzio C, Werner L, Takeda D, Awoyemi BC, Pomerantz MM, Yamada H, Sooriakumaran P, Robinson BD, Leung R, Schinzel AC, Mills I, Ross-Adams H, Neal DE, Kido M, Yamamoto T, ... ... Freedman ML, et al. Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis. Proceedings of the National Academy of Sciences of the United States of America. 109: 11252-7. PMID 22730461 DOI: 10.1073/Pnas.1200853109  1
2012 Miller AE, O'Connor P, Wolinsky JS, Confavreux C, Kappos L, Olsson TP, Truffinet P, Wang L, D'Castro L, Comi G, Freedman MS. Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 1625-32. PMID 22723573 DOI: 10.1177/1352458512450354  1
2012 Freedman MS, Wolinsky JS, Wamil B, Confavreux C, Comi G, Kappos L, Olsson TP, Miller A, Benzerdjeb H, Li H, Simonson C, O'Connor PW. Teriflunomide added to interferon-β in relapsing multiple sclerosis: a randomized phase II trial. Neurology. 78: 1877-85. PMID 22622860 DOI: 10.1212/WNL.0b013e318258f7d4  1
2012 Rihn JA, Radcliff K, Hilibrand AS, Anderson DT, Zhao W, Lurie J, Vaccaro AR, Freedman MK, Albert TJ, Weinstein JN. Does obesity affect outcomes of treatment for lumbar stenosis and degenerative spondylolisthesis? Analysis of the Spine Patient Outcomes Research Trial (SPORT). Spine. 37: 1933-46. PMID 22614793 DOI: 10.1097/BRS.0b013e31825e21b2  1
2012 Zarzana KJ, De Haan DO, Freedman MA, Hasenkopf CA, Tolbert MA. Optical properties of the products of α-dicarbonyl and amine reactions in simulated cloud droplets. Environmental Science & Technology. 46: 4845-51. PMID 22515474 DOI: 10.1021/Es2040152  1
2012 Penner IK, Stemper B, Calabrese P, Freedman MS, Polman CH, Edan G, Hartung HP, Miller DH, Montalbán X, Barkhof F, Pleimes D, Lanius V, Pohl C, Kappos L, Sandbrink R. Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 1466-71. PMID 22492127 DOI: 10.1177/1352458512442438  1
2012 Freedman MS. Do not treat from CIS onset: evaluate disease course and prognosis first--no (treat!). Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 394-5. PMID 22473501 DOI: 10.1177/1352458512440605  0.01
2012 Saccardi R, Freedman MS, Sormani MP, Atkins H, Farge D, Griffith LM, Kraft G, Mancardi GL, Nash R, Pasquini M, Martin R, Muraro PA. A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 825-34. PMID 22383228 DOI: 10.1177/1352458512438454  1
2012 Walker LA, Berard JA, Berrigan LI, Rees LM, Freedman MS. Detecting cognitive fatigue in multiple sclerosis: method matters. Journal of the Neurological Sciences. 316: 86-92. PMID 22336698 DOI: 10.1016/j.jns.2012.01.021  1
2012 Confavreux C, Li DK, Freedman MS, Truffinet P, Benzerdjeb H, Wang D, Bar-Or A, Traboulsee AL, Reiman LE, O'Connor PW. Long-term follow-up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety and efficacy results up to 8.5 years. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 1278-89. PMID 22307384 DOI: 10.1177/1352458512436594  1
2012 Murphy MJ, Grace GM, Tartaglia MC, Orange JB, Chen X, Rowe A, Findlater K, Kozak RI, Freedman M, Lee TY, Strong MJ. Widespread cerebral haemodynamics disturbances occur early in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 13: 202-9. PMID 22292841 DOI: 10.3109/17482968.2011.625569  1
2012 Freedman MS, Uccelli A. Neurorepair with mesenchymal stem cells: hope or hype? The Lancet. Neurology. 11: 123-5. PMID 22236383 DOI: 10.1016/S1474-4422(12)70001-7  1
2012 Freedman MS, Metzig C, Kappos L, Polman CH, Edan G, Hartung HP, Miller DH, Montalban X, Yarden J, Spector L, Fire E, Dotan N, Schwenke S, Lanius V, Sandbrink R, et al. Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysis. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 966-73. PMID 22183938 DOI: 10.1177/1352458511432327  1
2012 Comi G, De Stefano N, Freedman MS, Barkhof F, Polman CH, Uitdehaag BM, Casset-Semanaz F, Hennessy B, Moraga MS, Rocak S, Stubinski B, Kappos L. Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial. The Lancet. Neurology. 11: 33-41. PMID 22146409 DOI: 10.1016/S1474-4422(11)70262-9  1
2012 Dewal N, Hu Y, Freedman ML, Laframboise T, Pe'er I. Calling amplified haplotypes in next generation tumor sequence data. Genome Research. 22: 362-74. PMID 22090379 DOI: 10.1101/Gr.122564.111  1
2012 Saidenberg E, Freedman M, Fournier E, Lesley P, Goldman M. Transfusion Med Illustrated: hemoglobin C acquired through exchange transfusion. Transfusion. 52: 466. PMID 22032197 DOI: 10.1111/j.1537-2995.2011.03405.x  0.01
2012 Smith AM, Walker LA, Freedman MS, Berrigan LI, St Pierre J, Hogan MJ, Cameron I. Activation patterns in multiple sclerosis on the Computerized Tests of Information Processing. Journal of the Neurological Sciences. 312: 131-7. PMID 21862036 DOI: 10.1016/J.Jns.2011.08.003  1
2012 Edan G, Kappos L, Montalban X, Polman C, Freedman M, Hartung H, Miller D, Barkhof F, Lanius V, Stemper B, Pohl C, Sandbrink R, Pleimes D. Early Initiation of Interferon Beta-1b after a First Clinical Event Suggestive of Multiple Sclerosis: Clinical Outcomes and Use of Disease-Modifying Therapy from the BENEFIT Extension Study (PD5.002) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.Pd5.002  1
2011 Patsopoulos NA, Esposito F, Reischl J, Lehr S, Bauer D, Heubach J, Sandbrink R, Pohl C, Edan G, Kappos L, ... ... Freedman MS, et al. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Annals of Neurology. 70: 897-912. PMID 22190364 DOI: 10.1002/Ana.22609  1
2011 Pomerantz MM, Freedman ML. The genetics of cancer risk. Cancer Journal (Sudbury, Mass.). 17: 416-22. PMID 22157285 DOI: 10.1097/PPO.0b013e31823e5387  1
2011 Caffarra P, Gardini S, Zonato F, Concari L, Dieci F, Copelli S, Freedman M, Stracciari A, Venneri A. Italian norms for the Freedman version of the Clock Drawing Test. Journal of Clinical and Experimental Neuropsychology. 33: 982-8. PMID 22082081 DOI: 10.1080/13803395.2011.589373  0.01
2011 Krupinski EA, Patterson T, Norman CD, Roth Y, ElNasser Z, Abdeen Z, Noyek A, Sriharan A, Ignatieff A, Black S, Freedman M. Successful models for telehealth. Otolaryngologic Clinics of North America. 44: 1275-88, vii-viii. PMID 22032481 DOI: 10.1016/J.Otc.2011.08.004  1
2011 O'Connor P, Wolinsky JS, Confavreux C, Comi G, Kappos L, Olsson TP, Benzerdjeb H, Truffinet P, Wang L, Miller A, Freedman MS. Randomized trial of oral teriflunomide for relapsing multiple sclerosis. The New England Journal of Medicine. 365: 1293-303. PMID 21991951 DOI: 10.1056/NEJMoa1014656  1
2011 Freedman MS, Bar-Or A, Oger J, Traboulsee A, Patry D, Young C, Olsson T, Li D, Hartung HP, Krantz M, Ferenczi L, Verco T. A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS. Neurology. 77: 1551-60. PMID 21975206 DOI: 10.1212/WNL.0b013e318233b240  1
2011 Naglie G, Hogan DB, Krahn M, Black SE, Beattie BL, Patterson C, Macknight C, Freedman M, Borrie M, Byszewski A, Bergman H, Streiner D, Irvine J, Ritvo P, Comrie J, et al. Predictors of family caregiver ratings of patient quality of life in Alzheimer disease: cross-sectional results from the Canadian Alzheimer's Disease Quality of Life Study. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 19: 891-901. PMID 21946805 DOI: 10.1097/Jgp.0B013E3182006A7F  1
2011 Naglie G, Hogan DB, Krahn M, Beattie BL, Black SE, Macknight C, Freedman M, Patterson C, Borrie M, Bergman H, Byszewski A, Streiner D, Irvine J, Ritvo P, Comrie J, et al. Predictors of patient self-ratings of quality of life in Alzheimer disease: cross-sectional results from the Canadian Alzheimer's Disease Quality of Life Study. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 19: 881-90. PMID 21946804 DOI: 10.1097/Jgp.0B013E3182006A67  1
2011 Freedman MR, Wood H. A tool to identify older adults who are candidates for action planning to increase fruit and vegetable intake. Journal of Nutrition Education and Behavior. 43: 421-3. PMID 21906556 DOI: 10.1016/j.jneb.2011.02.012  0.01
2011 Sun T, Oh WK, Jacobus S, Regan M, Pomerantz M, Freedman ML, Lee GS, Kantoff PW. The impact of common genetic variations in genes of the sex hormone metabolic pathways on steroid hormone levels and prostate cancer aggressiveness. Cancer Prevention Research (Philadelphia, Pa.). 4: 2044-50. PMID 21900597 DOI: 10.1158/1940-6207.CAPR-11-0283  1
2011 Hartung HP, Freedman MS, Polman CH, Edan G, Kappos L, Miller DH, Montalbán X, Barkhof F, Petkau J, White R, Sahajpal V, Knappertz V, Beckmann K, Lanius V, Sandbrink R, et al. Interferon β-1b-neutralizing antibodies 5 years after clinically isolated syndrome. Neurology. 77: 835-43. PMID 21849647 DOI: 10.1212/Wnl.0B013E31822C90D7  1
2011 Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, van Swieten JC, Seelaar H, Dopper EG, Onyike CU, Hillis AE, Josephs KA, Boeve BF, Kertesz A, Seeley WW, ... ... Freedman M, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain : a Journal of Neurology. 134: 2456-77. PMID 21810890 DOI: 10.1093/Brain/Awr179  1
2011 Chow TW, Graff-Guerrero A, Verhoeff NP, Binns MA, Tang-Wai DF, Freedman M, Masellis M, Black SE, Wilson AA, Houle S, Pollock BG. Open-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementia. Neuropsychiatric Disease and Treatment. 7: 415-24. PMID 21792308 DOI: 10.2147/Ndt.S22635  1
2011 Galea I, Freedman MS, Thompson EJ. Cerebrospinal fluid analysis in the 2010 revised McDonald's multiple sclerosis diagnostic criteria. Annals of Neurology. 70: 183; author reply 18. PMID 21786311 DOI: 10.1002/ana.22466  1
2011 Acaster S, Swinburn P, Wang C, Stemper B, Beckmann K, Knappertz V, Pohl C, Sandbrink R, Gondek K, Edan G, Kappos L, Freedman M, Hartung HP, Arnason B, Comi G, et al. Can the functional assessment of multiple sclerosis adapt to changing needs? A psychometric validation in patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 1504-13. PMID 21757536 DOI: 10.1177/1352458511414039  1
2011 Zhao B, Zou J, Wang H, Johannsen E, Peng CW, Quackenbush J, Mar JC, Morton CC, Freedman ML, Blacklow SC, Aster JC, Bernstein BE, Kieff E. Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth. Proceedings of the National Academy of Sciences of the United States of America. 108: 14902-7. PMID 21746931 DOI: 10.1073/Pnas.1108892108  1
2011 Freedman M, Stuss DT. Theory of Mind in Parkinson's disease. Journal of the Neurological Sciences. 310: 225-7. PMID 21705020 DOI: 10.1016/j.jns.2011.06.004  1
2011 Henri-Bhargava A, Freedman M. Executive dysfunction in delayed radiation-induced leukoencephalopathy. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 183: 1401. PMID 21690227 DOI: 10.1503/cmaj.101879  1
2011 Uccelli A, Laroni A, Freedman MS. Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases. The Lancet. Neurology. 10: 649-56. PMID 21683930 DOI: 10.1016/S1474-4422(11)70121-1  1
2011 Chow TW, Gao F, Links KA, Ween JE, Tang-Wai DF, Ramirez J, Scott CJ, Freedman M, Stuss DT, Black SE. Visual rating versus volumetry to detect frontotemporal dementia. Dementia and Geriatric Cognitive Disorders. 31: 371-8. PMID 21625137 DOI: 10.1159/000328415  1
2011 Freedman ML, Monteiro AN, Gayther SA, Coetzee GA, Risch A, Plass C, Casey G, De Biasi M, Carlson C, Duggan D, James M, Liu P, Tichelaar JW, Vikis HG, You M, et al. Principles for the post-GWAS functional characterization of cancer risk loci. Nature Genetics. 43: 513-8. PMID 21614091 DOI: 10.1038/Ng.840  1
2011 Yang M, Xie W, Mostaghel E, Nakabayashi M, Werner L, Sun T, Pomerantz M, Freedman M, Ross R, Regan M, Sharifi N, Figg WD, Balk S, Brown M, Taplin ME, et al. SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 2565-73. PMID 21606417 DOI: 10.1200/Jco.2010.31.2405  1
2011 Catalona WJ, Bailey-Wilson JE, Camp NJ, Chanock SJ, Cooney KA, Easton DF, Eeles RA, FitzGerald LM, Freedman ML, Gudmundsson J, Kittles RA, Margulies EH, McGuire BB, Ostrander EA, Rebbeck TR, et al. National Cancer Institute Prostate Cancer Genetics Workshop. Cancer Research. 71: 3442-6. PMID 21558387 DOI: 10.1158/0008-5472.Can-11-0314  1
2011 Penney KL, Sinnott JA, Fall K, Pawitan Y, Hoshida Y, Kraft P, Stark JR, Fiorentino M, Perner S, Finn S, Calza S, Flavin R, Freedman ML, Setlur S, Sesso HD, et al. mRNA expression signature of Gleason grade predicts lethal prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 2391-6. PMID 21537050 DOI: 10.1200/Jco.2010.32.6421  1
2011 Freedman MR, Keast DR. White potatoes, including french fries, contribute shortfall nutrients to children's and adolescents' diets. Nutrition Research (New York, N.Y.). 31: 270-7. PMID 21530800 DOI: 10.1016/J.Nutres.2011.03.006  1
2011 Freedman MR, Connors R. Point-of-purchase nutrition information influences food-purchasing behaviors of college students: a pilot study. Journal of the American Dietetic Association. 111: S42-6. PMID 21515134 DOI: 10.1016/j.jada.2011.03.008  1
2011 Wolfberg E, Ekboir A, Faiman G, Finzi J, Freedman M, Heath A, Martínez de Cipolatti MC. [Mourning and depression, from the attachment theory perspective]. Vertex (Buenos Aires, Argentina). 22: 19-27. PMID 21505643  0.01
2011 Freedman MT, Lo SC, Seibel JC, Bromley CM. Lung nodules: improved detection with software that suppresses the rib and clavicle on chest radiographs. Radiology. 260: 265-73. PMID 21493789 DOI: 10.1148/radiol.11100153  1
2011 Hasenkopf CA, Freedman MA, Beaver MR, Toon OB, Tolbert MA. Potential climatic impact of organic haze on early Earth. Astrobiology. 11: 135-49. PMID 21417943 DOI: 10.1089/Ast.2010.0541  1
2011 Pomerantz MM, Werner L, Xie W, Regan MM, Lee GS, Sun T, Evan C, Petrozziello G, Nakabayashi M, Oh WK, Kantoff PW, Freedman ML. Association of prostate cancer risk Loci with disease aggressiveness and prostate cancer-specific mortality. Cancer Prevention Research (Philadelphia, Pa.). 4: 719-28. PMID 21367958 DOI: 10.1158/1940-6207.CAPR-10-0292  1
2011 Walker LA, Mendella PD, Stewart A, Freedman MS, Smith AM. Meaningful change in cognition in multiple sclerosis: method matters. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 38: 282-8. PMID 21320834  1
2011 Cusimano MD, Rewilak D, Stuss DT, Barrera-Martinez JC, Salehi F, Freedman M. Normal-pressure hydrocephalus: is there a genetic predisposition? The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 38: 274-81. PMID 21320833  1
2011 Freedman MS, Cohen JA. Meta-analysis of bone marrow transplantation treatment studies: mixing 'apples and oranges'. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 131-2. PMID 21296831 DOI: 10.1177/1352458510394941  1
2011 Vasudevan JM, Freedman MK, Beredjiklian PK, Deluca PF, Nazarian LN. Common peroneal entrapment neuropathy secondary to a popliteal lipoma: ultrasound superior to magnetic resonance imaging for diagnosis. Pm & R : the Journal of Injury, Function, and Rehabilitation. 3: 274-9. PMID 21277280 DOI: 10.1016/j.pmrj.2010.09.014  1
2011 Freedman MK, Hilibrand AS, Blood EA, Zhao W, Albert TJ, Vaccaro AR, Oleson CV, Morgan TS, Weinstein JN. The impact of diabetes on the outcomes of surgical and nonsurgical treatment of patients in the spine patient outcomes research trial. Spine. 36: 290-307. PMID 21270715 DOI: 10.1097/Brs.0B013E3181Ef9D8C  1
2011 Freedman MR, Waldrop J. Freshman orientation sessions can teach incoming students about healthful lifestyles. Journal of Nutrition Education and Behavior. 43: 69-70. PMID 21216368 DOI: 10.1016/j.jneb.2010.07.008  0.01
2011 Freedman MS. Improving long-term follow-up studies of immunomodulatory therapies. Neurology. 76: S35-8. PMID 21205681 DOI: 10.1212/WNL.0b013e3182050599  0.01
2011 Freedman MS. Long-term follow-up of clinical trials of multiple sclerosis therapies. Neurology. 76: S26-34. PMID 21205679 DOI: 10.1212/WNL.0b013e318205051d  0.01
2011 Chen Z, Freedman MS. γδ T cells and multiple sclerosis: Friends, foes, or both? Autoimmunity Reviews. 10: 364-7. PMID 21195807 DOI: 10.1016/J.Autrev.2010.12.005  1
2011 Grace GM, Orange JB, Rowe A, Findlater K, Freedman M, Strong MJ. Neuropsychological functioning in PLS: a comparison with ALS. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 38: 88-97. PMID 21156436 DOI: 10.1017/S0317167100120803  1
2011 Sun T, Mary LG, Oh WK, Freedman ML, Pomerantz M, Pienta KJ, Kantoff PW. Inherited variants in the chemokine CCL2 gene and prostate cancer aggressiveness in a Caucasian cohort. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 1546-52. PMID 21135144 DOI: 10.1158/1078-0432.CCR-10-2015  1
2011 Nielsen JM, Pohl C, Polman CH, Barkhof F, Freedman MS, Edan G, Miller DH, Bauer L, Sandbrink R, Kappos L, Uitdehaag BMJ. Correction: Prognostic implications of a carefully performed neurological assessment in patients with a first event suggestive of multiple sclerosis Bmc Neurology. 11. DOI: 10.1186/1471-2377-11-19  1
2010 Grisanzio C, Freedman ML. Chromosome 8q24-Associated Cancers and MYC. Genes & Cancer. 1: 555-9. PMID 21779458 DOI: 10.1177/1947601910381380  1
2010 Freedman MR, Rubinstein RJ. Obesity and Food Choices Among Faculty and Staff at a Large Urban University. Journal of American College Health : J of Ach. 59: 205-10. PMID 21186451 DOI: 10.1080/07448481.2010.502203  0.01
2010 Tao Y, Lo SC, Freedman MT, Makariou E, Xuan J. Multilevel learning-based segmentation of ill-defined and spiculated masses in mammograms. Medical Physics. 37: 5993-6002. PMID 21158311  1
2010 Pomerantz MM, Freedman ML. Genetics of prostate cancer risk. The Mount Sinai Journal of Medicine, New York. 77: 643-54. PMID 21105126 DOI: 10.1002/msj.20222  1
2010 Pomerantz MM, Shrestha Y, Flavin RJ, Regan MM, Penney KL, Mucci LA, Stampfer MJ, Hunter DJ, Chanock SJ, Schafer EJ, Chan JA, Tabernero J, Baselga J, Richardson AL, Loda M, ... ... Freedman ML, et al. Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesis. Plos Genetics. 6: e1001204. PMID 21085629 DOI: 10.1371/Journal.Pgen.1001204  1
2010 Craik FI, Bialystok E, Freedman M. Delaying the onset of Alzheimer disease: bilingualism as a form of cognitive reserve. Neurology. 75: 1726-9. PMID 21060095 DOI: 10.1212/Wnl.0B013E3181Fc2A1C  1
2010 Links KA, Merims D, Binns MA, Freedman M, Chow TW. Prevalence of primitive reflexes and Parkinsonian signs in dementia. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 37: 601-7. PMID 21059505  1
2010 Penney KL, Pyne S, Schumacher FR, Sinnott JA, Mucci LA, Kraft PL, Ma J, Oh WK, Kurth T, Kantoff PW, Giovannucci EL, Stampfer MJ, Hunter DJ, Freedman ML. Genome-wide association study of prostate cancer mortality. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 2869-76. PMID 20978177 DOI: 10.1158/1055-9965.Epi-10-0601  1
2010 Feldon PJ, Murray PE, Burch JG, Meister M, Freedman MA. Diode laser debonding of ceramic brackets. American Journal of Orthodontics and Dentofacial Orthopedics : Official Publication of the American Association of Orthodontists, Its Constituent Societies, and the American Board of Orthodontics. 138: 458-62. PMID 20889051 DOI: 10.1016/j.ajodo.2008.11.028  1
2010 Sun T, Lee GS, Oh WK, Pomerantz M, Yang M, Xie W, Freedman ML, Kantoff PW. Single-nucleotide polymorphisms in p53 pathway and aggressiveness of prostate cancer in a Caucasian population. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 5244-51. PMID 20855462 DOI: 10.1158/1078-0432.CCR-10-1261  1
2010 Costello F, Hodge W, Pan YI, Eggenberger E, Freedman MS. Using retinal architecture to help characterize multiple sclerosis patients. Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie. 45: 520-6. PMID 20838421 DOI: 10.3129/i10-063  1
2010 Tombaugh TN, Berrigan LI, Walker LA, Freedman MS. The Computerized Test of Information Processing (CTIP) offers an alternative to the PASAT for assessing cognitive processing speed in individuals with multiple sclerosis. Cognitive and Behavioral Neurology : Official Journal of the Society For Behavioral and Cognitive Neurology. 23: 192-8. PMID 20829669 DOI: 10.1097/WNN.0b013e3181cc8bd4  1
2010 Freedman MR. A "Healthy Pizza Kitchen" nutrition education program at a Children's Health Museum. Journal of Nutrition Education and Behavior. 42: 353-4. PMID 20828669 DOI: 10.1016/j.jneb.2010.01.012  0.01
2010 LaFramboise T, Dewal N, Wilkins K, Pe'er I, Freedman ML. Allelic selection of amplicons in glioblastoma revealed by combining somatic and germline analysis. Plos Genetics. 6: e1001086. PMID 20824129 DOI: 10.1371/Journal.Pgen.1001086  1
2010 Spreng RN, Rosen HJ, Strother S, Chow TW, Diehl-Schmid J, Freedman M, Graff-Radford NR, Hodges JR, Lipton AM, Mendez MF, Morelli SA, Black SE, Miller BL, Levine B. Occupation attributes relate to location of atrophy in frontotemporal lobar degeneration. Neuropsychologia. 48: 3634-41. PMID 20800604 DOI: 10.1016/J.Neuropsychologia.2010.08.020  1
2010 Leff SS, Thomas DE, Vaughn NA, Thomas NA, MacEvoy JP, Freedman MA, Abdul-Kabir S, Woodlock J, Guerra T, Bradshaw AS, Woodburn EM, Myers RK, Fein JA. Using community-based participatory research to develop the PARTNERS youth violence prevention program. Progress in Community Health Partnerships : Research, Education, and Action. 4: 207-16. PMID 20729611 DOI: 10.1353/Cpr.2010.0005  1
2010 Freedman MA, Baustian KJ, Wise ME, Tolbert MA. Characterizing the morphology of organic aerosols at ambient temperature and pressure. Analytical Chemistry. 82: 7965-72. PMID 20726528 DOI: 10.1021/Ac101437W  1
2010 Freedman M, Rock G. Analysis of the products of cryoprecipitation: RiCoF is deficient in cryosupernatant plasma. Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society For Haemapheresis. 43: 179-82. PMID 20719565 DOI: 10.1016/j.transci.2010.07.004  0.01
2010 Nguyen PL, Ma J, Chavarro JE, Freedman ML, Lis R, Fedele G, Fiore C, Qiu W, Fiorentino M, Finn S, Penney KL, Eisenstein A, Schumacher FR, Mucci LA, Stampfer MJ, et al. Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 3958-64. PMID 20679621 DOI: 10.1200/Jco.2009.27.0793  1
2010 Darlington PJ, Boivin MN, Renoux C, François M, Galipeau J, Freedman MS, Atkins HL, Cohen JA, Solchaga L, Bar-Or A. Reciprocal Th1 and Th17 regulation by mesenchymal stem cells: Implication for multiple sclerosis. Annals of Neurology. 68: 540-5. PMID 20661924 DOI: 10.1002/ana.22065  1
2010 Freedman MR, Connors R. Point-of-purchase nutrition information influences food-purchasing behaviors of college students: a pilot study. Journal of the American Dietetic Association. 110: 1222-6. PMID 20656098 DOI: 10.1016/j.jada.2010.05.002  1
2010 Newell MK, Tobin RP, Cabrera JH, Sorensen MB, Huckstep A, Villalobos-Menuey EM, Burnett M, McCrea E, Harvey CP, Buddiga A, Bar-Or A, Freedman MS, Nalbantoglu J, Arbour N, Zamvil SS, et al. TLR-mediated B cell activation results in ectopic CLIP expression that promotes B cell-dependent inflammation. Journal of Leukocyte Biology. 88: 779-89. PMID 20631258 DOI: 10.1189/jlb.0410237  1
2010 Sun T, Lee GS, Werner L, Pomerantz M, Oh WK, Kantoff PW, Freedman ML. Inherited variations in AR, ESR1, and ESR2 genes are not associated with prostate cancer aggressiveness or with efficacy of androgen deprivation therapy. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 1871-8. PMID 20615892 DOI: 10.1158/1055-9965.EPI-10-0216  1
2010 Beaver MR, Freedman MA, Hasenkopf CA, Tolbert MA. Cooling enhancement of aerosol particles due to surfactant precipitation. The Journal of Physical Chemistry. A. 114: 7070-6. PMID 20536216 DOI: 10.1021/Jp102437Q  1
2010 Lindström S, Ma J, Altshuler D, Giovannucci E, Riboli E, Albanes D, Allen NE, Berndt SI, Boeing H, Bueno-de-Mesquita HB, Chanock SJ, Dunning AM, Feigelson HS, Gaziano JM, Haiman CA, ... ... Freedman ML, et al. A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. The Journal of Clinical Endocrinology and Metabolism. 95: E121-7. PMID 20534771 DOI: 10.1210/jc.2009-1911  1
2010 Freedman MR. Gender, residence and ethnicity affect freshman BMI and dietary habits. American Journal of Health Behavior. 34: 513-24. PMID 20524881 DOI: 10.5555/ajhb.2010.34.5.513  0.01
2010 Schumacher FR, Cheng I, Freedman ML, Mucci L, Allen NE, Pollak MN, Hayes RB, Stram DO, Canzian F, Henderson BE, Hunter DJ, Virtamo J, Manjer J, Gaziano JM, Kolonel LN, et al. A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians. Human Molecular Genetics. 19: 3089-101. PMID 20484221 DOI: 10.1093/Hmg/Ddq210  1
2010 Ahmadiyeh N, Pomerantz MM, Grisanzio C, Herman P, Jia L, Almendro V, He HH, Brown M, Liu XS, Davis M, Caswell JL, Beckwith CA, Hills A, Macconaill L, Coetzee GA, ... ... Freedman ML, et al. 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC. Proceedings of the National Academy of Sciences of the United States of America. 107: 9742-6. PMID 20453196 DOI: 10.1073/Pnas.0910668107  1
2010 Freedman MR. Development, evaluation, and validation of environmental assessment tools to evaluate the college nutrition environment. Journal of American College Health : J of Ach. 58: 565-8. PMID 20452933 DOI: 10.1080/07448481003686026  0.01
2010 Freedman MR, Nickell A. Impact of after-school nutrition workshops in a public library setting. Journal of Nutrition Education and Behavior. 42: 192-6. PMID 20434074 DOI: 10.1016/j.jneb.2009.07.003  0.01
2010 O'Connor KC, Lopez-Amaya C, Gagne D, Lovato L, Moore-Odom NH, Kennedy J, Krupp L, Tenembaum S, Ness J, Belman A, Boyko A, Bykova O, Mah JK, Stoian CA, Waubant E, ... ... Freedman MS, et al. Anti-myelin antibodies modulate clinical expression of childhood multiple sclerosis. Journal of Neuroimmunology. 223: 92-9. PMID 20381173 DOI: 10.1016/J.Jneuroim.2010.02.019  1
2010 Khan O, Filippi M, Freedman MS, Barkhof F, Dore-Duffy P, Lassmann H, Trapp B, Bar-Or A, Zak I, Siegel MJ, Lisak R. Chronic cerebrospinal venous insufficiency and multiple sclerosis. Annals of Neurology. 67: 286-90. PMID 20373339 DOI: 10.1002/Ana.22001  1
2010 Vosoughi R, Freedman MS. Therapy of MS. Clinical Neurology and Neurosurgery. 112: 365-85. PMID 20362388 DOI: 10.1016/j.clineuro.2010.03.010  1
2010 Pasquini MC, Griffith LM, Arnold DL, Atkins HL, Bowen JD, Chen JT, Freedman MS, Kraft GH, Mancardi GL, Martin R, Muraro PA, Nash RA, Racke MK, Storek J, Saccardi R. Hematopoietic stem cell transplantation for multiple sclerosis: collaboration of the CIBMTR and EBMT to facilitate international clinical studies. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 16: 1076-83. PMID 20304084 DOI: 10.1016/j.bbmt.2010.03.012  1
2010 Freedman MR. School health fairs show potential to improve short-term learning. Journal of Nutrition Education and Behavior. 42: 137-8. PMID 20219725 DOI: 10.1016/j.jneb.2009.08.005  0.01
2010 Freedman MR, Alvarez KP. Early childhood feeding: assessing knowledge, attitude, and practices of multi-ethnic child-care providers. Journal of the American Dietetic Association. 110: 447-51. PMID 20184996 DOI: 10.1016/j.jada.2009.11.018  0.01
2010 Kaye ED, Petrovic-Poljak A, Verhoeff NP, Freedman M. Frontotemporal dementia and pharmacologic interventions. The Journal of Neuropsychiatry and Clinical Neurosciences. 22: 19-29. PMID 20160206 DOI: 10.1176/appi.neuropsych.22.1.19  0.01
2010 Ouimet MC, Simons-Morton BG, Zador PL, Lerner ND, Freedman M, Duncan GD, Wang J. Using the U.S. National Household Travel Survey to estimate the impact of passenger characteristics on young drivers' relative risk of fatal crash involvement. Accident; Analysis and Prevention. 42: 689-94. PMID 20159095 DOI: 10.1016/j.aap.2009.10.017  1
2010 Freedman MS, Bar-Or A, Atkins HL, Karussis D, Frassoni F, Lazarus H, Scolding N, Slavin S, Le Blanc K, Uccelli A. The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group. Multiple Sclerosis (Houndmills, Basingstoke, England). 16: 503-10. PMID 20086020 DOI: 10.1177/1352458509359727  1
2010 Oh J, Stokes K, Tyndel F, Freedman M. Progressive cognitive decline in a patient with isolated chronic neurosarcoidosis. The Neurologist. 16: 50-3. PMID 20065799 DOI: 10.1097/NRL.0b013e31819f959b  1
2010 Whitman EJ, Pomerantz M, Chen Y, Chamberlin MM, Furusato B, Gao C, Ali A, Ravindranath L, Dobi A, Sesterhenn IA, Sestrehenn IA, McLeod DG, Srivastava S, Freedman M, Petrovics G. Prostate cancer risk allele specific for African descent associates with pathologic stage at prostatectomy. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 1-8. PMID 20056617 DOI: 10.1158/1055-9965.EPI-08-1111  1
2010 Liu CC, Lo SC, Freedman MT, Lasser ME, Kula J, Sarcone A, Wang Y. PE-CMOS based C-scan ultrasound for foreign object detection in soft tissue. Frontiers in Bioscience (Elite Edition). 2: 231-40. PMID 20036873  1
2010 Freedman MR, Brochado C. Reducing portion size reduces food intake and plate waste. Obesity (Silver Spring, Md.). 18: 1864-6. PMID 20035274 DOI: 10.1038/oby.2009.480  0.01
2010 Dewal N, Freedman ML, LaFramboise T, Pe'er I. Power to detect selective allelic amplification in genome-wide scans of tumor data. Bioinformatics (Oxford, England). 26: 518-28. PMID 20031965 DOI: 10.1093/Bioinformatics/Btp694  1
2010 Coetzee GA, Jia L, Frenkel B, Henderson BE, Tanay A, Haiman CA, Freedman ML. A systematic approach to understand the functional consequences of non-protein coding risk regions. Cell Cycle (Georgetown, Tex.). 9: 256-9. PMID 20023379 DOI: 10.4161/Cc.9.2.10419  1
2010 Petzold A, Altintas A, Andreoni L, Bartos A, Berthele A, Blankenstein MA, Buee L, Castellazzi M, Cepok S, Comabella M, Constantinescu CS, Deisenhammer F, Deniz G, Erten G, Espiño M, ... ... Freedman MS, et al. Neurofilament ELISA validation. Journal of Immunological Methods. 352: 23-31. PMID 19857497 DOI: 10.1016/J.Jim.2009.09.014  1
2010 Freedman MT. Comments on "Computer-aided detection in full-field digital mammography in a clinical population: performance of radiologist and technologists". Breast Cancer Research and Treatment. 120: 507-8. PMID 19551501 DOI: 10.1007/s10549-009-0443-9  0.01
2009 Gullan RL, Feinberg BE, Freedman MA, Jawad A, Leff SS. Using Participatory Action Research to Design an Intervention Integrity System in the Urban Schools. School Mental Health. 1: 118-130. PMID 20428475 DOI: 10.1007/s12310-009-9006-9  0.01
2009 Freedman MA. Partnership issues and sexuality. Clinical Obstetrics and Gynecology. 52: 656-65. PMID 20393417 DOI: 10.1097/GRF.0b013e3181bf4804  1
2009 Levine BA, Ingeholm ML, Prior F, Mun SK, Freedman M, Weissman D, Attfield M, Wolfe A, Petsonk E. Conversion to use of digital chest images for surveillance of coal workers' pneumoconiosis (black lung). Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual Conference. 2009: 2161-3. PMID 19963535 DOI: 10.1109/IEMBS.2009.5332422  1
2009 Moraal B, Pohl C, Uitdehaag BM, Polman CH, Edan G, Freedman MS, Hartung HP, Kappos L, Miller DH, Montalban X, Lanius V, Sandbrink R, Barkhof F. Magnetic resonance imaging predictors of conversion to multiple sclerosis in the BENEFIT study. Archives of Neurology. 66: 1345-52. PMID 19901165 DOI: 10.1001/Archneurol.2009.243  1
2009 Freedman MA, Hasenkopf CA, Beaver MR, Tolbert MA. Optical properties of internally mixed aerosol particles composed of dicarboxylic acids and ammonium sulfate. The Journal of Physical Chemistry. A. 113: 13584-92. PMID 19877658 DOI: 10.1021/Jp906240Y  1
2009 Hawker K, O'Connor P, Freedman MS, Calabresi PA, Antel J, Simon J, Hauser S, Waubant E, Vollmer T, Panitch H, Zhang J, Chin P, Smith CH. Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial. Annals of Neurology. 66: 460-71. PMID 19847908 DOI: 10.1002/Ana.21867  1
2009 Fejerman L, Haiman CA, Reich D, Tandon A, Deo RC, John EM, Ingles SA, Ambrosone CB, Bovbjerg DH, Jandorf LH, Davis W, Ciupak G, Whittemore AS, Press MF, Ursin G, ... ... Freedman ML, et al. An admixture scan in 1,484 African American women with breast cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 3110-7. PMID 19843668 DOI: 10.1158/1055-9965.Epi-09-0464  1
2009 Freedman MS. 'Time is brain' also in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 15: 1133-4. PMID 19808740 DOI: 10.1177/1352458509345920  0.01
2009 Engel WK, Fazekas F, Lublin FD, Li D, Freedman MS, Hartung HP, Rieckmann P, Soelberg Sørensen P, Maas-Enriquez M, Sommerauer B, Hanna K. Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial. Neurology. 73: 1077; author reply 1. PMID 19786702 DOI: 10.1212/WNL.0b013e3181ab6b81  1
2009 Kappos L, Freedman MS, Polman CH, Edan G, Hartung HP, Miller DH, Montalbán X, Barkhof F, Radü EW, Metzig C, Bauer L, Lanius V, Sandbrink R, Pohl C. Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial. The Lancet. Neurology. 8: 987-97. PMID 19748319 DOI: 10.1016/S1474-4422(09)70237-6  1
2009 Zhang J, Song YH, Brannigan BW, Wahrer DC, Schiripo TA, Harris PL, Haserlat SM, Ulkus LE, Shannon KM, Garber JE, Freedman ML, Henderson BE, Zou L, Sgroi DC, Haber DA, et al. Prevalence and functional analysis of sequence variants in the ATR checkpoint mediator Claspin. Molecular Cancer Research : McR. 7: 1510-6. PMID 19737971 DOI: 10.1158/1541-7786.Mcr-09-0033  1
2009 Yamada H, Penney KL, Takahashi H, Katoh T, Yamano Y, Yamakado M, Kimura T, Kuruma H, Kamata Y, Egawa S, Freedman ML. Replication of prostate cancer risk loci in a Japanese case-control association study. Journal of the National Cancer Institute. 101: 1330-6. PMID 19726753 DOI: 10.1093/jnci/djp287  1
2009 Links KA, Chow TW, Binns M, Freedman M, Stuss DT, Scott CJ, Ramirez J, Black SE. Apathy is not associated with basal ganglia atrophy in frontotemporal dementia. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 17: 819-21. PMID 19700954 DOI: 10.1097/Jgp.0B013E3181B047Ff  1
2009 Reingold SC, Steiner JP, Polman CH, Cohen JA, Freedman MS, Kappos L, Thompson AJ, Wolinsky JS. The challenge of follow-on biologics for treatment of multiple sclerosis. Neurology. 73: 552-9. PMID 19687456 DOI: 10.1212/WNL.0b013e3181b2a6ce  1
2009 Jia L, Landan G, Pomerantz M, Jaschek R, Herman P, Reich D, Yan C, Khalid O, Kantoff P, Oh W, Manak JR, Berman BP, Henderson BE, Frenkel B, Haiman CA, ... Freedman M, et al. Functional enhancers at the gene-poor 8q24 cancer-linked locus. Plos Genetics. 5: e1000597. PMID 19680443 DOI: 10.1371/Journal.Pgen.1000597  1
2009 Freedman MS, Cohen B, Dhib-Jalbut S, Jeffery D, Reder AT, Sandberg-Wollheim M, Weinstock-Guttman B. Recognizing and treating suboptimally controlled multiple sclerosis: steps toward regaining command. Current Medical Research and Opinion. 25: 2459-70. PMID 19678753 DOI: 10.1185/03007990903158364  1
2009 Bar-Or A, Oger J, Gibbs E, Niino M, Aziz T, Renoux C, Alatab S, Shi FD, Campagnolo D, Jalili F, Rhodes S, Yamashita T, Fan B, Freedman MS, Panitch H, et al. Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression? Multiple Sclerosis (Houndmills, Basingstoke, England). 15: 959-64. PMID 19667022 DOI: 10.1177/1352458509106230  1
2009 Frank G, Pressman E, Ophir R, Althan L, Shaked R, Freedman M, Shen S, Firon N. Transcriptional profiling of maturing tomato (Solanum lycopersicum L.) microspores reveals the involvement of heat shock proteins, ROS scavengers, hormones, and sugars in the heat stress response. Journal of Experimental Botany. 60: 3891-908. PMID 19628571 DOI: 10.1093/jxb/erp234  0.01
2009 Chow TW, Binns MA, Cummings JL, Lam I, Black SE, Miller BL, Freedman M, Stuss DT, van Reekum R. Apathy symptom profile and behavioral associations in frontotemporal dementia vs dementia of Alzheimer type. Archives of Neurology. 66: 888-93. PMID 19597092 DOI: 10.1001/Archneurol.2009.92  1
2009 Pomerantz MM, Ahmadiyeh N, Jia L, Herman P, Verzi MP, Doddapaneni H, Beckwith CA, Chan JA, Hills A, Davis M, Yao K, Kehoe SM, Lenz HJ, Haiman CA, Yan C, ... ... Freedman ML, et al. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nature Genetics. 41: 882-4. PMID 19561607 DOI: 10.1038/Ng.403  1
2009 Pomerantz MM, Beckwith CA, Regan MM, Wyman SK, Petrovics G, Chen Y, Hawksworth DJ, Schumacher FR, Mucci L, Penney KL, Stampfer MJ, Chan JA, Ardlie KG, Fritz BR, Parkin RK, ... ... Freedman ML, et al. Evaluation of the 8q24 prostate cancer risk locus and MYC expression. Cancer Research. 69: 5568-74. PMID 19549893 DOI: 10.1158/0008-5472.CAN-09-0387  1
2009 Dittmann KA, Freedman MR. Body awareness, eating attitudes, and spiritual beliefs of women practicing yoga. Eating Disorders. 17: 273-92. PMID 19548145 DOI: 10.1080/10640260902991111  0.01
2009 Strong MJ, Grace GM, Freedman M, Lomen-Hoerth C, Woolley S, Goldstein LH, Murphy J, Shoesmith C, Rosenfeld J, Leigh PN, Bruijn L, Ince P, Figlewicz D. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 10: 131-46. PMID 19462523 DOI: 10.1080/17482960802654364  1
2009 Cheng CY, Kao WH, Patterson N, Tandon A, Haiman CA, Harris TB, Xing C, John EM, Ambrosone CB, Brancati FL, Coresh J, Press MF, Parekh RS, Klag MJ, Meoni LA, ... ... Freedman ML, et al. Admixture mapping of 15,280 African Americans identifies obesity susceptibility loci on chromosomes 5 and X. Plos Genetics. 5: e1000490. PMID 19461885 DOI: 10.1371/Journal.Pgen.1000490  1
2009 Nielsen JM, Pohl C, Polman CH, Barkhof F, Freedman MS, Edan G, Miller DH, Bauer L, Sandbrink R, Kappos L, Uitdehaag BM. MRI characteristics are predictive for CDMS in monofocal, but not in multifocal patients with a clinically isolated syndrome. Bmc Neurology. 9: 19. PMID 19457248 DOI: 10.1186/1471-2377-9-19  1
2009 Tammemagi MC, Freedman MT, Pinsky PF, Oken MM, Hu P, Riley TL, Ragard LR, Berg CD, Prorok PC. Prediction of true positive lung cancers in individuals with abnormal suspicious chest radiographs: a prostate, lung, colorectal, and ovarian cancer screening trial study. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 4: 710-21. PMID 19404219 DOI: 10.1097/JTO.0b013e31819e77ce  1
2009 Atkins H, Freedman M. Immune ablation followed by autologous hematopoietic stem cell transplantation for the treatment of poor prognosis multiple sclerosis. Methods in Molecular Biology (Clifton, N.J.). 549: 231-46. PMID 19378207 DOI: 10.1007/978-1-60327-931-4_16  0.01
2009 Penney KL, Salinas CA, Pomerantz M, Schumacher FR, Beckwith CA, Lee GS, Oh WK, Sartor O, Ostrander EA, Kurth T, Ma J, Mucci L, Stanford JL, Kantoff PW, Hunter DJ, ... ... Freedman ML, et al. Evaluation of 8q24 and 17q risk loci and prostate cancer mortality. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 3223-30. PMID 19366828 DOI: 10.1158/1078-0432.Ccr-08-2733  1
2009 Freedman M, Chang EH, Zhou Q, Pirollo KF. Nanodelivery of MRI contrast agent enhances sensitivity of detection of lung cancer metastases. Academic Radiology. 16: 627-37. PMID 19345904 DOI: 10.1016/j.acra.2008.12.002  1
2009 Smith AM, Walker LA, Freedman MS, DeMeulemeester C, Hogan MJ, Cameron I. fMRI investigation of disinhibition in cognitively impaired patients with multiple sclerosis. Journal of the Neurological Sciences. 281: 58-63. PMID 19344919 DOI: 10.1016/J.Jns.2009.02.366  1
2009 Freedman MS, Laks J, Dotan N, Altstock RT, Dukler A, Sindic CJ. Anti-alpha-glucose-based glycan IgM antibodies predict relapse activity in multiple sclerosis after the first neurological event. Multiple Sclerosis (Houndmills, Basingstoke, England). 15: 422-30. PMID 19324980 DOI: 10.1177/1352458508101944  0.01
2009 Costello F, Hodge W, Pan YI, Freedman M, DeMeulemeester C. Differences in retinal nerve fiber layer atrophy between multiple sclerosis subtypes. Journal of the Neurological Sciences. 281: 74-9. PMID 19303605 DOI: 10.1016/J.Jns.2009.02.354  1
2009 Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E, Khoury MJ, Cohen B, Davey-Smith G, Grimshaw J, Scheet P, Gwinn M, Williamson RE, Zou GY, Hutchings K, ... ... Freedman M, et al. STrengthening the REporting of Genetic Association studies (STREGA)--an extension of the STROBE statement. European Journal of Clinical Investigation. 39: 247-66. PMID 19297801 DOI: 10.1111/J.1365-2362.2009.02125.X  1
2009 Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E, Khoury MJ, Cohen B, Davey-Smith G, Grimshaw J, Scheet P, Gwinn M, Williamson RE, Zou GY, Hutchings K, ... ... Freedman M, et al. STrengthening the REporting of Genetic Association Studies (STREGA)--an extension of the STROBE statement. Genetic Epidemiology. 33: 581-98. PMID 19278015 DOI: 10.1002/Gepi.20410  1
2009 Freedman M, Kaunitz AM, Reape KZ, Hait H, Shu H. Twice-weekly synthetic conjugated estrogens vaginal cream for the treatment of vaginal atrophy. Menopause (New York, N.Y.). 16: 735-41. PMID 19252451 DOI: 10.1097/gme.0b013e318199e734  0.01
2009 Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E, Khoury MJ, Cohen B, Davey-Smith G, Grimshaw J, Scheet P, Gwinn M, Williamson RE, Zou GY, Hutchings K, ... ... Freedman M, et al. Strengthening the reporting of genetic association studies (STREGA): an extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statement. Journal of Clinical Epidemiology. 62: 597-608.e4. PMID 19217256 DOI: 10.1016/J.Jclinepi.2008.12.004  1
2009 Odedina FT, Akinremi TO, Chinegwundoh F, Roberts R, Yu D, Reams RR, Freedman ML, Rivers B, Green BL, Kumar N. Prostate cancer disparities in Black men of African descent: a comparative literature review of prostate cancer burden among Black men in the United States, Caribbean, United Kingdom, and West Africa. Infectious Agents and Cancer. 4: S2. PMID 19208207 DOI: 10.1186/1750-9378-4-S1-S2  1
2009 Li C, Freedman M, Boyer-Chu L. Championing school-located influenza immunization: the school nurse's role. The Journal of School Nursing : the Official Publication of the National Association of School Nurses. 25: 18S-28S. PMID 19197010 DOI: 10.1177/1059840508330067  1
2009 Li C, Freedman M. Seasonal influenza: an overview. The Journal of School Nursing : the Official Publication of the National Association of School Nurses. 25: 4S-12S. PMID 19197008 DOI: 10.1177/1059840508330066  1
2009 Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E, Khoury MJ, Cohen B, Davey-Smith G, Grimshaw J, Scheet P, Gwinn M, Williamson RE, Zou GY, Hutchings K, ... ... Freedman M, et al. STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. Plos Medicine. 6: e22. PMID 19192942 DOI: 10.1371/Journal.Pmed.1000022  1
2009 Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E, Khoury MJ, Cohen B, Davey-Smith G, Grimshaw J, Scheet P, Gwinn M, Williamson RE, Zou GY, Hutchings K, ... ... Freedman M, et al. STrengthening the REporting of Genetic Association studies (STREGA): an extension of the STROBE Statement. Annals of Internal Medicine. 150: 206-15. PMID 19189911 DOI: 10.7326/0003-4819-150-3-200902030-00011  1
2009 Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E, Khoury MJ, Cohen B, Davey-Smith G, Grimshaw J, Scheet P, Gwinn M, Williamson RE, Zou GY, Hutchings K, ... ... Freedman M, et al. Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement. European Journal of Epidemiology. 24: 37-55. PMID 19189221 DOI: 10.1007/S10654-008-9302-Y  1
2009 Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E, Khoury MJ, Cohen B, Davey-Smith G, Grimshaw J, Scheet P, Gwinn M, Williamson RE, Zou GY, Hutchings K, ... ... Freedman M, et al. Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement. Human Genetics. 125: 131-51. PMID 19184668 DOI: 10.1007/S00439-008-0592-7  1
2009 Siritho S, Freedman MS. The prognostic significance of cerebrospinal fluid in multiple sclerosis. Journal of the Neurological Sciences. 279: 21-5. PMID 19181345 DOI: 10.1016/j.jns.2008.12.029  0.01
2009 Baker JM, Lewis VA, Fernandez CV, Duval M, Crooks BN, Yuille K, Freedman MH, Doyle JJ, Dror Y. Allogeneic hematopoietic stem cell transplantation of patients with FA and high risk features using fludarabine without radiation. Pediatric Blood & Cancer. 52: 683-5. PMID 19156855 DOI: 10.1002/pbc.21921  1
2009 Malonda J, Campbell J, Crivianu-Gaita D, Freedman MH, Stevens P, Laxer RM. Lessons learned from a privacy breach at an academic health science centre. Healthcare Quarterly (Toronto, Ont.). 12: 61-5, 2. PMID 19142065  0.01
2009 MacLean HJ, Freedman MS. Multiple sclerosis: following clues from cause to cure. The Lancet. Neurology. 8: 6-8. PMID 19081501 DOI: 10.1016/S1474-4422(08)70272-2  1
2009 Odedina FT, Yu D, Akinremi TO, Reams RR, Freedman ML, Kumar N. Prostate cancer cognitive-behavioral factors in a West African population. Journal of Immigrant and Minority Health / Center For Minority Public Health. 11: 258-67. PMID 19051034 DOI: 10.1007/s10903-008-9212-9  1
2009 Gast MJ, Freedman MA, Vieweg AJ, De Melo NR, Girão MJ, Zinaman MJ. A randomized study of low-dose conjugated estrogens on sexual function and quality of life in postmenopausal women. Menopause (New York, N.Y.). 16: 247-56. PMID 19034054 DOI: 10.1097/gme.0b013e318184c440  1
2008 Freedman MA, Becker JS, Sibener SJ. Effects of film thickness and molecular weight on the interfacial dynamics of atactic poly(methyl methacrylate). The Journal of Physical Chemistry. B. 112: 16090-6. PMID 19367795 DOI: 10.1021/Jp8062614  1
2008 Merims D, Freedman M. Cognitive and behavioural impairment in Parkinson's disease. International Review of Psychiatry (Abingdon, England). 20: 364-73. PMID 18925485 DOI: 10.1080/09540260802095123  1
2008 Arnold DL, Campagnolo D, Panitch H, Bar-Or A, Dunn J, Freedman MS, Gazda SK, Vollmer T. Glatiramer acetate after mitoxantrone induction improves MRI markers of lesion volume and permanent tissue injury in MS. Journal of Neurology. 255: 1473-8. PMID 18854910 DOI: 10.1007/s00415-008-0911-x  1
2008 Murphy MJ, Grace GM, Tartaglia MC, Orange JB, Chen X, Rowe A, Findlater K, Kozak RI, Freedman M, Strong MJ, Lee TY. Cerebral haemodynamic changes accompanying cognitive impairment in primary lateral sclerosis. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 9: 359-68. PMID 18850337 DOI: 10.1080/17482960802411740  1
2008 Clarke DE, van Reekum R, Simard M, Streiner DL, Conn D, Cohen T, Freedman M. Apathy in dementia: clinical and sociodemographic correlates. The Journal of Neuropsychiatry and Clinical Neurosciences. 20: 337-47. PMID 18806238 DOI: 10.1176/appi.neuropsych.20.3.337  1
2008 Miller DH, Weinshenker BG, Filippi M, Banwell BL, Cohen JA, Freedman MS, Galetta SL, Hutchinson M, Johnson RT, Kappos L, Kira J, Lublin FD, McFarland HF, Montalban X, Panitch H, et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Multiple Sclerosis (Houndmills, Basingstoke, England). 14: 1157-74. PMID 18805839 DOI: 10.1177/1352458508096878  1
2008 Mistry Y, Freedman M, Sweeney K, Hollenbeck C. Infant-feeding practices of low-income Vietnamese American women. Journal of Human Lactation : Official Journal of International Lactation Consultant Association. 24: 406-14. PMID 18776168 DOI: 10.1177/0890334408318833  0.01
2008 Bonderson P, Freedman M, Nayak C. Measurement-only topological quantum computation. Physical Review Letters. 101: 010501. PMID 18764095 DOI: 10.1103/PhysRevLett.101.010501  1
2008 Zhang Y, An HS, Tannoury C, Thonar EJ, Freedman MK, Anderson DG. Biological treatment for degenerative disc disease: implications for the field of physical medicine and rehabilitation. American Journal of Physical Medicine & Rehabilitation / Association of Academic Physiatrists. 87: 694-702. PMID 18716481 DOI: 10.1097/PHM.0b013e31817c1945  0.01
2008 Chow TW, Binns MA, Freedman M, Stuss DT, Ramirez J, Scott CJ, Black S. Overlap in frontotemporal atrophy between normal aging and patients with frontotemporal dementias. Alzheimer Disease and Associated Disorders. 22: 327-35. PMID 18695590 DOI: 10.1097/Wad.0B013E31818026C4  1
2008 Freedman MS. Induction vs. escalation of therapy for relapsing multiple sclerosis: the evidence. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 29: S250-2. PMID 18690508 DOI: 10.1007/s10072-008-0953-y  0.01
2008 Freedman MA, Becker JS, Rosenbaum AW, Sibener SJ. Polymer surface and thin film vibrational dynamics of poly(methyl methacrylate), polybutadiene, and polystyrene. The Journal of Chemical Physics. 129: 044906. PMID 18681677 DOI: 10.1063/1.2939018  1
2008 Fazekas F, Lublin FD, Li D, Freedman MS, Hartung HP, Rieckmann P, Sørensen PS, Maas-Enriquez M, Sommerauer B, Hanna K. Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial. Neurology. 71: 265-71. PMID 18645164 DOI: 10.1212/01.wnl.0000318281.98220.6f  1
2008 Freedman MS, Forrestal FG. Canadian treatment optimization recommendations (TOR) as a predictor of disease breakthrough in patients with multiple sclerosis treated with interferon beta-1a: analysis of the PRISMS study. Multiple Sclerosis (Houndmills, Basingstoke, England). 14: 1234-41. PMID 18632774 DOI: 10.1177/1352458508093892  0.01
2008 Chow TW, Izenberg A, Binns MA, Freedman M, Stuss DT, Scott CJ, Ramirez J, Black SE. Magnetic resonance imaging in frontotemporal dementia shows subcortical atrophy. Dementia and Geriatric Cognitive Disorders. 26: 79-88. PMID 18617738 DOI: 10.1159/000144028  1
2008 Freedman M, Jayasundara H, Stassen LF. Idiopathic isolated unilateral hypoglossal nerve palsy: a diagnosis of exclusion. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 106: e22-6. PMID 18585607 DOI: 10.1016/j.tripleo.2008.02.024  1
2008 Percy M, Moalem S, Garcia A, Somerville MJ, Hicks M, Andrews D, Azad A, Schwarz P, Beheshti Zavareh R, Birkan R, Choo C, Chow V, Dhaliwal S, Duda V, Kupferschmidt AL, ... ... Freedman M, et al. Involvement of ApoE E4 and H63D in sporadic Alzheimer's disease in a folate-supplemented Ontario population. Journal of Alzheimer's Disease : Jad. 14: 69-84. PMID 18525129 DOI: 10.3233/Jad-2008-14107  1
2008 Darlington PJ, Podjaski C, Horn KE, Costantino S, Blain M, Saikali P, Chen Z, Baker KA, Newcombe J, Freedman M, Wiseman PW, Bar-Or A, Kennedy TE, Antel JP. Innate immune-mediated neuronal injury consequent to loss of astrocytes. Journal of Neuropathology and Experimental Neurology. 67: 590-9. PMID 18520777 DOI: 10.1097/Nen.0B013E3181772Cf6  1
2008 Ward AC, Gits J, Majeed F, Aprikyan AA, Lewis RS, O'Sullivan LA, Freedman M, Shigdar S, Touw IP, Dale DC, Dror Y. Functional interaction between mutations in the granulocyte colony-stimulating factor receptor in severe congenital neutropenia. British Journal of Haematology. 142: 653-6. PMID 18513286 DOI: 10.1111/j.1365-2141.2008.07224.x  1
2008 Chen Z, Freedman MS. CD16+ gammadelta T cells mediate antibody dependent cellular cytotoxicity: potential mechanism in the pathogenesis of multiple sclerosis. Clinical Immunology (Orlando, Fla.). 128: 219-27. PMID 18501678 DOI: 10.1016/J.Clim.2008.03.513  1
2008 Chertkow H, Massoud F, Nasreddine Z, Belleville S, Joanette Y, Bocti C, Drolet V, Kirk J, Freedman M, Bergman H. Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 178: 1273-85. PMID 18458258 DOI: 10.1503/Cmaj.070797  1
2008 Freedman MS, Hughes B, Mikol DD, Bennett R, Cuffel B, Divan V, LaVallee N, Al-Sabbagh A. Efficacy of disease-modifying therapies in relapsing remitting multiple sclerosis: a systematic comparison. European Neurology. 60: 1-11. PMID 18437041 DOI: 10.1159/000127972  0.01
2008 Rolita L, Freedman M. Over-the-counter medication use in older adults. Journal of Gerontological Nursing. 34: 8-17. PMID 18429375  0.01
2008 Vollmer T, Panitch H, Bar-Or A, Dunn J, Freedman MS, Gazda SK, Campagnolo D, Deutsch F, Arnold DL. Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 14: 663-70. PMID 18424479 DOI: 10.1177/1352458507085759  1
2008 McKinnon MC, Nica EI, Sengdy P, Kovacevic N, Moscovitch M, Freedman M, Miller BL, Black SE, Levine B. Autobiographical memory and patterns of brain atrophy in frontotemporal lobar degeneration. Journal of Cognitive Neuroscience. 20: 1839-53. PMID 18370601 DOI: 10.1162/Jocn.2008.20126  1
2008 Polman CH, Reingold SC, Barkhof F, Calabresi PA, Clanet M, Cohen JA, Cutter GR, Freedman MS, Kappos L, Lublin FD, McFarland HF, Metz LM, Miller AE, Montalban X, O'Connor PW, et al. Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment. Neurology. 70: 1134-40. PMID 18362273 DOI: 10.1212/01.Wnl.0000306410.84794.4D  1
2008 Overton EA, Kornbluth ID, Saulino MF, Holding MY, Freedman MK. Interventions in chronic pain management. 6. Interventional approaches to chronic pain management. Archives of Physical Medicine and Rehabilitation. 89: S61-4. PMID 18295653 DOI: 10.1016/j.apmr.2007.12.007  1
2008 Freedman MK, Saulino MF, Overton EA, Holding MY, Kornbluth ID. Interventions in chronic pain management. 5. Approaches to medication and lifestyle in chronic pain syndromes. Archives of Physical Medicine and Rehabilitation. 89: S56-60. PMID 18295652 DOI: 10.1016/j.apmr.2007.12.002  1
2008 Kornbluth ID, Freedman MK, Holding MY, Overton EA, Saulino MF. Interventions in chronic pain management. 4. Monitoring progress and compliance in chronic pain management. Archives of Physical Medicine and Rehabilitation. 89: S51-5. PMID 18295651 DOI: 10.1016/j.apmr.2007.12.009  1
2008 Saulino MF, Kornbluth ID, Overton EA, Holding MY, Freedman MK. Interventions in chronic pain management. 3. Evaluation and management of lumbar pain syndromes. Archives of Physical Medicine and Rehabilitation. 89: S47-50. PMID 18295650 DOI: 10.1016/j.apmr.2007.12.008  1
2008 Freedman MK, Overton EA, Saulino MF, Holding MY, Kornbluth ID. Interventions in chronic pain management. 2. Diagnosis of cervical and thoracic pain syndromes. Archives of Physical Medicine and Rehabilitation. 89: S41-6. PMID 18295649 DOI: 10.1016/j.apmr.2007.12.004  1
2008 Holding MY, Saulino MF, Overton EA, Kornbluth ID, Freedman MK. Interventions in chronic pain management. 1. Update on important definitions in pain management. Archives of Physical Medicine and Rehabilitation. 89: S38-40. PMID 18295648 DOI: 10.1016/j.apmr.2007.12.011  1
2008 Ross RW, Oh WK, Xie W, Pomerantz M, Nakabayashi M, Sartor O, Taplin ME, Regan MM, Kantoff PW, Freedman M. Inherited variation in the androgen pathway is associated with the efficacy of androgen-deprivation therapy in men with prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 842-7. PMID 18281655 DOI: 10.1200/JCO.2007.13.6804  1
2008 Chen JT, Collins DL, Atkins HL, Freedman MS, Arnold DL. Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions. Annals of Neurology. 63: 254-62. PMID 18257039 DOI: 10.1002/ana.21302  1
2008 Freedman MT, Osicka T. Heat maps: an aid for data analysis and understanding of ROC CAD experiments. Academic Radiology. 15: 249-59. PMID 18206625 DOI: 10.1016/j.acra.2007.07.010  1
2008 Tamimi RM, Brugge JS, Freedman ML, Miron A, Iglehart JD, Colditz GA, Hankinson SE. Circulating colony stimulating factor-1 and breast cancer risk. Cancer Research. 68: 18-21. PMID 18172291 DOI: 10.1158/0008-5472.Can-07-3234  1
2008 Chen Z, Freedman MS. Correlation of specialized CD16(+) gammadelta T cells with disease course and severity in multiple sclerosis. Journal of Neuroimmunology. 194: 147-52. PMID 18155780 DOI: 10.1016/J.Jneuroim.2007.11.010  1
2008 Haiman CA, Hsu C, de Bakker PI, Frasco M, Sheng X, Van Den Berg D, Casagrande JT, Kolonel LN, Le Marchand L, Hankinson SE, Han J, Dunning AM, Pooley KA, Freedman ML, Hunter DJ, et al. Comprehensive association testing of common genetic variation in DNA repair pathway genes in relationship with breast cancer risk in multiple populations. Human Molecular Genetics. 17: 825-34. PMID 18056155 DOI: 10.1093/Hmg/Ddm354  1
2008 Polman C, Kappos L, Freedman MS, Edan G, Hartung HP, Miller DH, Montalbán X, Barkhof F, Selmaj K, Uitdehaag BM, Dahms S, Bauer L, Pohl C, Sandbrink R. Subgroups of the BENEFIT study: risk of developing MS and treatment effect of interferon beta-1b. Journal of Neurology. 255: 480-7. PMID 18004635 DOI: 10.1007/S00415-007-0733-2  1
2008 Metz I, Lucchinetti CF, Openshaw H, Garcia-Merino A, Lassmann H, Freedman MS, Azzarelli B, Kolar OJ, Atkins HL, Brück W. Autologous hematopoietic stem cell transplantation: The glass seems to be half full for aggressive, early forms of MS and half empty for advanced MS [2] Brain. 131: e90. DOI: 10.1093/brain/awm181  1
2008 Bar-Or A, Touil T, Kebir H, Jalili F, Hilliker K, Theoret G, Bowman M, Prat A, Freedman M, Atkins H. OR.96. The Abrogation of Inflammatory Disease Activity in MS Patients Treated with Immune Ablation and Autologous Haematopoetic Stem-cell Transplantation (AHSCT) is Associated with Significant Decreases in ThIL-17, but not Th1 Responses Clinical Immunology. 127. DOI: 10.1016/J.Clim.2008.03.103  1
2007 Ahn J, Albanes D, Peters U, Schatzkin A, Lim U, Freedman M, Chatterjee N, Andriole GL, Leitzmann MF, Hayes RB. Dairy products, calcium intake, and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 2623-30. PMID 18086766 DOI: 10.1158/1055-9965.Epi-07-0601  1
2007 Piwko C, Desjardins OB, Bereza BG, Machado M, Jaszewski B, Freedman MS, Einarson TR, Iskedjian M. Pain due to multiple sclerosis: analysis of the prevalence and economic burden in Canada. Pain Research & Management : the Journal of the Canadian Pain Society = Journal De La Sociã©Tã© Canadienne Pour Le Traitement De La Douleur. 12: 259-65. PMID 18080044  0.01
2007 Chang EI, Loh SA, Ceradini DJ, Chang EI, Lin SE, Bastidas N, Aarabi S, Chan DA, Freedman ML, Giaccia AJ, Gurtner GC. Age decreases endothelial progenitor cell recruitment through decreases in hypoxia-inducible factor 1alpha stabilization during ischemia. Circulation. 116: 2818-29. PMID 18040029 DOI: 10.1161/Circulationaha.107.715847  1
2007 Tammemagi CM, Freedman MT, Church TR, Oken MM, Hocking WG, Kvale PA, Hu P, Riley TL, Ragard LR, Prorok PC, Berg CD. Factors associated with human small aggressive non small cell lung cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 2082-9. PMID 17932357 DOI: 10.1158/1055-9965.EPI-07-0251  1
2007 Barkhof F, Polman CH, Radue EW, Kappos L, Freedman MS, Edan G, Hartung HP, Miller DH, Montalbán X, Poppe P, de Vos M, Lasri F, Bauer L, Dahms S, Wagner K, et al. Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year results. Archives of Neurology. 64: 1292-8. PMID 17846268 DOI: 10.1001/Archneur.64.9.1292  1
2007 Sajan FD, Martiniuk F, Marcus DL, Frey WH, Hite R, Bordayo EZ, Freedman ML. Apoptotic gene expression in Alzheimer's disease hippocampal tissue. American Journal of Alzheimer's Disease and Other Dementias. 22: 319-28. PMID 17712163 DOI: 10.1177/1533317507302447  1
2007 Banwell B, Krupp L, Kennedy J, Tellier R, Tenembaum S, Ness J, Belman A, Boiko A, Bykova O, Waubant E, Mah JK, Stoian C, Kremenchutzky M, Bardini MR, Ruggieri M, ... Freedman M, et al. Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. The Lancet. Neurology. 6: 773-81. PMID 17689148 DOI: 10.1016/S1474-4422(07)70196-5  1
2007 Kappos L, Freedman MS, Polman CH, Edan G, Hartung HP, Miller DH, Montalbán X, Barkhof F, Radü EW, Bauer L, Dahms S, Lanius V, Pohl C, Sandbrink R. Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study. Lancet (London, England). 370: 389-97. PMID 17679016 DOI: 10.1016/S0140-6736(07)61194-5  1
2007 Nielsen JM, Moraal B, Polman CH, Poppe P, de Vos M, Freedman MS, Kappos L, Barjhof F, Bauer L, Pohl C, Sandbrink R, Hartung HP, Uitdehaag BMJ. Classification of patients with a clinically isolated syndrome based on signs and symptoms is supported by magnetic resonance imaging results Multiple Sclerosis. 13: 717-721. PMID 17613598 DOI: 10.1177/1352458506074684  1
2007 Reicker LI, Tombaugh TN, Walker L, Freedman MS. Reaction time: An alternative method for assessing the effects of multiple sclerosis on information processing speed. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 22: 655-64. PMID 17532182 DOI: 10.1016/j.acn.2007.04.008  1
2007 Feiguin A, Trebst S, Ludwig AW, Troyer M, Kitaev A, Wang Z, Freedman MH. Interacting anyons in topological quantum liquids: the golden chain. Physical Review Letters. 98: 160409. PMID 17501404 DOI: 10.1103/Physrevlett.98.160409  1
2007 Duddy M, Niino M, Adatia F, Hebert S, Freedman M, Atkins H, Kim HJ, Bar-Or A. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. Journal of Immunology (Baltimore, Md. : 1950). 178: 6092-9. PMID 17475834 DOI: 10.4049/Jimmunol.178.10.6092  1
2007 Freedman M, Quinn F, O'Sullivan M. Single unit CAD/CAM restorations: a literature review. Journal of the Irish Dental Association. 53: 38-45. PMID 17396765  0.01
2007 Metz I, Lucchinetti CF, Openshaw H, Garcia-Merino A, Lassmann H, Freedman MS, Atkins HL, Azzarelli B, Kolar OJ, Brück W. Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis. Brain : a Journal of Neurology. 130: 1254-62. PMID 17293360 DOI: 10.1093/brain/awl370  1
2007 Saikali P, Antel JP, Newcombe J, Chen Z, Freedman M, Blain M, Cayrol R, Prat A, Hall JA, Arbour N. NKG2D-mediated cytotoxicity toward oligodendrocytes suggests a mechanism for tissue injury in multiple sclerosis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 1220-8. PMID 17267578 DOI: 10.1523/Jneurosci.4402-06.2007  1
2007 Kuhle J, Pohl C, Mehling M, Edan G, Freedman MS, Hartung HP, Polman CH, Miller DH, Montalban X, Barkhof F, Bauer L, Dahms S, Lindberg R, Kappos L, Sandbrink R. Lack of association between antimyelin antibodies and progression to multiple sclerosis. The New England Journal of Medicine. 356: 371-8. PMID 17251533 DOI: 10.1056/Nejmoa063602  1
2006 Dale DC, Bolyard AA, Schwinzer BG, Pracht G, Bonilla MA, Boxer L, Freedman MH, Donadieu J, Kannourakis G, Alter BP, Cham BP, Winkelstein J, Kinsey SE, Zeidler C, Welte K. The Severe Chronic Neutropenia International Registry: 10-Year Follow-up Report. Supportive Cancer Therapy. 3: 220-31. PMID 18632498 DOI: 10.3816/SCT.2006.n.020  1
2006 O'Connor PW, Li D, Freedman MS, Bar-Or A, Rice GPA, Confavreux C, Paty DW, Stewart JA, Scheyer R. A phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses Neurology. 66: 894-900. PMID 16567708 DOI: 10.1212/01.Wnl.0000203121.04509.31  1
Show low-probability matches.